Central Lab Market By Type (Specialized Testing, High-volume Safety Testing, Others); By Offering (Project Management, Global Logistics and Sample Management, Data Management and Analytics Solutions, Specimen Management and Storage, Third-party Lab Management, Flow Cytometry, Immunoassays and Biomarker Analysis, Clinical Trial Kit Production, Global Digital Pathology, Others); By End User (Biotech Companies, Pharmaceutical Companies, CROs, Others); By Areas (Oncology, Infectious Diseases, Auto-immune Disorders, Immunology, Gastroenterology, Cardiology, Endocrinology, Respiratory Disorders, Others); By Application (Research, Commercial); By Region (North America (U.S., Canada, Mexico, Rest Of North America), Europe (France, The UK, Spain, Germany, Italy, Denmark, Finland, Iceland, Sweden, Norway, Belgium, The Netherlands, Luxembourg, Rest of Europe), Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia, Rest of Asia Pacific, Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa) Latin America (Brazil, Argentina, Rest of Latin America)) - Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2022 – 2030
Industry Trends
In the recent years, clinical trial has driven the central lab industry to the next level as it has forever altered the ways because of their global scope. The size of clinical studies is growing, with more investigator sites distributed throughout more nations. Laboratories are being challenged to maintain standards in a variety of contexts while also staying on top of regulatory obligations as a result of their global expansion. Central labs are expanding globally and establishing operations in a variety of foreign areas. The necessity to develop effective solutions is critical along with maintaining their consistency in testing and achieving the desired results. With the rapid advancement of diagnostics and the growth of available efficacy indicators over the last two decades, the basis of central lab functions has evolved. As some aspects of drug development become more targeted, central laboratories have the ability to broaden their scope beyond safety and efficacy tests to incorporate specialised assays that look at patient and patient group genomic profiles. Pharmaceutical companies are looking forward to reduce their cost of development as well as manufacturing their products wherein the central lab services are commonly used which has contributed towards the steady growth of central lab market globally.
In terms of revenue, global central lab market was valued at US$ 2644.88 Mn in 2021 growing at a CAGR of 6.2% over the forecast period (2022 – 2030). The study analyses the market in terms of revenue across all the major regions, which have been bifurcated into countries.
Global Central Lab Market Revenue & Forecast, (US$ Million), 2015 – 2030
Type Outlook:
Based on type, the global central lab market is segmented into specialized testing, high-volume safety testing and others. Specialized testing is anticipated to witness highest growth rate over the forecast period. Specialized testing is gaining importance as pharmaceutical and biotechnology companies are focusing on research and development of various new medical products. Central labs play a very important role in clinical trials specialized testing as special attention is required to molecular genetics, specific diagnoses, and continuous diagnosis of subtypes of the disease. Central labs provide a combinable data generated from the same analytic method platform to correlate and standardize results. Furthermore, high volume safety testing are also being prominent in the central lab market as for instance, an infectious outbreak significantly increases laboratory worker responsibilities, with increased amount of specimen testing, higher pressure to get results back promptly and no room for errors. Additionally, as clinical trials generate huge volumes of data, it has generated avenues for data management and analytics, which are of crucial significance for the end users. These development, hence, showcases positive growth prospects for global central lab market over the forecast period.
Offering Outlook:
Based on offering, the global central lab market is segmented into project management, global logistics and sample management, data management and analytics solutions, specimen management and storage, third-party lab management, flow cytometry, immunoassays and biomarker analysis, clinical trial kit production, global digital pathology and others. Global logistics and sample management along with specimen management and storage obtained a considerable market share in 2021. Specimen management and storage held a crucial significance in clinical trials and drug development processes owing to rising development of personalized medicine. The specimens collected for these trials may be sent to three or four locations during the course of a clinical trial kit's journey, some to a clinical trial site for local testing, others to hospitals, and still others to third parties such as labs or biorepositories. Furthermore, as lab testing and support services have become more complicated and global, cold chain logistics have become increasingly vital, not just for drug makers, but also for central laboratories. During and after clinical trials, sample management is critical and strategies for assuring high-quality, adequately stored specimen samples have become even more important.
End User Outlook:
Based on end user, the global central lab market is segmented into biotech companies, pharmaceutical companies, CROs and others. Biotech companies and CRO’s are expected to be the fastest growing segment in the market over the forecast period. Biotech businesses are driving innovation to address unmet medical needs, which is fuelling the pharmaceutical pipeline. It needs skill and experience to navigate a quickly changing and increasingly complex environment, which is why central labs are in such high demand. Thus to cater to these rising requirements by the biotech companies, the leading players in the central lab market are focussing on expanding their central lab offering and testing capabilities. For instance, Q2 Solutions offers operational knowledge, testing strategies and capabilities in multiple therapeutic areas. Almost all of the world's well-known biopharmaceutical corporations and contract research organisations now use central labs to conduct clinical trials. The regulatory landscape will likely continue to evolve slowly, in contrast to the fast-paced opportunities and problems that come with managing new diagnostic technology and data analytics solutions.
Region Outlook:
North America held the highest share in the global central lab market. In United States, the rise in clinical trials for drug developments has led to an increase demand for central lab services. Moreover, biotech and pharmaceutical companies are looking forward to collaborate on yearly basis with single or multiple labs or either opting for merger and acquisitions to have better access to central labs to fasten their clinical trials. For instance, in February 2022, Cerba Research merged with Viroclinics-DDL, a global specialist virology and immunology contract research organisation (CRO) to expand their diagnostic solutions for clinical trials. Thus, these factors also showcase healthy growth for the global central lab market over the forecast period.
Competitive Landscape
The report provides both, qualitative and quantitative research of global central lab market, as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analysed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
Some of the players operating in the global central lab market are:
- ACM Global Laboratories
- Cerba Research
- EKF DIAGNOSTICS HOLDINGS PLC
- Eurofins Central Laboratory
- ICON plc
- INTERLAB Central Lab Services
- LabConnect
- Labcorp Drug Development
- Medpace
- oncquest.net
- PPD Inc.
- Q2 Solutions.
- Other Market Participants
Global Central Lab Market:
- By Type
- Specialized Testing
- High-volume Safety Testing
- Others
- By Offering
- Project Management
- Global Logistics and Sample Management
- Data Management and Analytics Solutions
- Specimen Management and Storage
- Third-party Lab Management
- Flow Cytometry, Immunoassays and Biomarker Analysis
- Clinical Trial Kit Production
- Global Digital Pathology
- Others
- By End User
- Biotech Companies
- Pharmaceutical Companies
- CROs
- Others
- By Areas
- Oncology
- Infectious Diseases
- Auto-immune Disorders
- Immunology
- Gastroenterology
- Cardiology
- Endocrinology
- Respiratory Disorders
- Others
- By Application
- Research
- Commercial
- By Region
- North America
- S.
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
- North America
Table of Contents
1. Market
Scope
1.1. Market
Segmentation
1.2. Years
Considered
1.2.1. Historic
Years: 2015 - 2021
1.2.2. Base
Year: 2021
1.2.3. Forecast
Years: 2022 – 2030
2. Key Target
Audiences
3. Research
Methodology
3.1. Primary
Research
3.1.1. Research
Questionnaire
3.1.2. Global
Percentage Breakdown
3.1.3. Primary
Interviews: Key Opinion Leaders (KOLs)
3.2. Secondary
Research
3.2.1. Paid
Databases
3.2.2. Secondary
Sources
3.3. Market
Size Estimates
3.3.1. Top-Down
Approach
3.3.2. Bottom-Up
Approach
3.4. Data
Triangulation Methodology
3.5. Research
Assumptions
4. Recommendations
and Insights from AMI’s Perspective**
5. Holistic
Overview of Central Lab Market
6. Market
Synopsis: Central Lab Market
7. Central Lab
Market Analysis: Qualitative Perspective
7.1. Introduction
7.1.1. Product
Definition
7.1.2. Industry
Development
7.2. Market
Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.3. Trends in
Central Lab Market
7.4. Market
Determinants Radar Chart
7.5. Macro-Economic
and Micro-Economic Indicators: Central Lab Market
7.6. Porter’s
Five Force Analysis
7.7. Impact of
Covid-19 on Central Lab Market
8. Global
Central Lab Market Analysis and Forecasts, 2022 – 2030
8.1. Overview
8.1.1. Global
Central Lab Market Revenue (US$ Mn)
8.2. Global
Central Lab Market Revenue (US$ Mn) and Forecasts, By Type
8.2.1. Specialized
testing
8.2.1.1. Definition
8.2.1.2. Market
Estimation and Penetration, 2015 - 2021
8.2.1.3. Market
Forecast, 2022 - 2030
8.2.1.4. Compound
Annual Growth Rate (CAGR)
8.2.1.5. Regional
Bifurcation
8.2.1.5.1. North
America
8.2.1.5.1.1. Market
Estimation, 2015 - 2021
8.2.1.5.1.2. Market
Forecast, 2022 - 2030
8.2.1.5.2. Europe
8.2.1.5.2.1. Market
Estimation, 2015 - 2021
8.2.1.5.2.2. Market
Forecast, 2022 - 2030
8.2.1.5.3. Asia
Pacific
8.2.1.5.3.1. Market
Estimation, 2015 - 2021
8.2.1.5.3.2. Market
Forecast, 2022 - 2030
8.2.1.5.4. Middle
East and Africa
8.2.1.5.4.1. Market
Estimation, 2015 - 2021
8.2.1.5.4.2. Market
Forecast, 2022 - 2030
8.2.1.5.5. Latin
America
8.2.1.5.5.1. Market
Estimation, 2015 - 2021
8.2.1.5.5.2. Market
Forecast, 2022 - 2030
8.2.2. High-volume
safety testing
8.2.2.1. Definition
8.2.2.2. Market
Estimation and Penetration, 2015 - 2021
8.2.2.3. Market
Forecast, 2022 - 2030
8.2.2.4. Compound
Annual Growth Rate (CAGR)
8.2.2.5. Regional
Bifurcation
8.2.2.5.1. North
America
8.2.2.5.1.1. Market
Estimation, 2015 - 2021
8.2.2.5.1.2. Market
Forecast, 2022 - 2030
8.2.2.5.2. Europe
8.2.2.5.2.1. Market
Estimation, 2015 - 2021
8.2.2.5.2.2. Market
Forecast, 2022 - 2030
8.2.2.5.3. Asia
Pacific
8.2.2.5.3.1. Market
Estimation, 2015 - 2021
8.2.2.5.3.2. Market
Forecast, 2022 - 2030
8.2.2.5.4. Middle
East and Africa
8.2.2.5.4.1. Market
Estimation, 2015 - 2021
8.2.2.5.4.2. Market
Forecast, 2022 - 2030
8.2.2.5.5. Latin
America
8.2.2.5.5.1. Market
Estimation, 2015 - 2021
8.2.2.5.5.2. Market
Forecast, 2022 - 2030
8.2.3. Others
8.2.3.1. Definition
8.2.3.2. Market
Estimation and Penetration, 2015 - 2021
8.2.3.3. Market
Forecast, 2022 - 2030
8.2.3.4. Compound
Annual Growth Rate (CAGR)
8.2.3.5. Regional
Bifurcation
8.2.3.5.1. North
America
8.2.3.5.1.1. Market
Estimation, 2015 - 2021
8.2.3.5.1.2. Market
Forecast, 2022 - 2030
8.2.3.5.2. Europe
8.2.3.5.2.1. Market
Estimation, 2015 - 2021
8.2.3.5.2.2. Market
Forecast, 2022 - 2030
8.2.3.5.3. Asia
Pacific
8.2.3.5.3.1. Market
Estimation, 2015 - 2021
8.2.3.5.3.2. Market
Forecast, 2022 - 2030
8.2.3.5.4. Middle
East and Africa
8.2.3.5.4.1. Market
Estimation, 2015 - 2021
8.2.3.5.4.2. Market
Forecast, 2022 - 2030
8.2.3.5.5. Latin
America
8.2.3.5.5.1. Market
Estimation, 2015 - 2021
8.2.3.5.5.2. Market
Forecast, 2022 - 2030
8.3. Key
Segment for Channelling Investments
8.3.1. By Type
9. Global
Central Lab Market Analysis and Forecasts, 2022 – 2030
9.1. Overview
9.2. Global
Central Lab Market Revenue (US$ Mn) and Forecasts, By Offering
9.2.1. Project
management
9.2.1.1. Definition
9.2.1.2. Market
Estimation and Penetration, 2015 - 2021
9.2.1.3. Market
Forecast, 2022 - 2030
9.2.1.4. Compound
Annual Growth Rate (CAGR)
9.2.1.5. Regional
Bifurcation
9.2.1.5.1. North
America
9.2.1.5.1.1. Market
Estimation, 2015 - 2021
9.2.1.5.1.2. Market
Forecast, 2022 - 2030
9.2.1.5.2. Europe
9.2.1.5.2.1. Market
Estimation, 2015 - 2021
9.2.1.5.2.2. Market
Forecast, 2022 - 2030
9.2.1.5.3. Asia
Pacific
9.2.1.5.3.1. Market
Estimation, 2015 - 2021
9.2.1.5.3.2. Market
Forecast, 2022 - 2030
9.2.1.5.4. Middle
East and Africa
9.2.1.5.4.1. Market
Estimation, 2015 - 2021
9.2.1.5.4.2. Market
Forecast, 2022 - 2030
9.2.1.5.5. Latin
America
9.2.1.5.5.1. Market
Estimation, 2015 - 2021
9.2.1.5.5.2. Market
Forecast, 2022 - 2030
9.2.2. Global
logistics and sample management
9.2.2.1. Definition
9.2.2.2. Market
Estimation and Penetration, 2015 - 2021
9.2.2.3. Market
Forecast, 2022 - 2030
9.2.2.4. Compound
Annual Growth Rate (CAGR)
9.2.2.5. Regional
Bifurcation
9.2.2.5.1. North
America
9.2.2.5.1.1. Market
Estimation, 2015 - 2021
9.2.2.5.1.2. Market
Forecast, 2022 - 2030
9.2.2.5.2. Europe
9.2.2.5.2.1. Market
Estimation, 2015 - 2021
9.2.2.5.2.2. Market
Forecast, 2022 - 2030
9.2.2.5.3. Asia
Pacific
9.2.2.5.3.1. Market
Estimation, 2015 - 2021
9.2.2.5.3.2. Market
Forecast, 2022 - 2030
9.2.2.5.4. Middle
East and Africa
9.2.2.5.4.1. Market
Estimation, 2015 - 2021
9.2.2.5.4.2. Market
Forecast, 2022 - 2030
9.2.2.5.5. Latin
America
9.2.2.5.5.1. Market
Estimation, 2015 - 2021
9.2.2.5.5.2. Market
Forecast, 2022 - 2030
9.2.3. Data
management and analytics solutions
9.2.3.1. Definition
9.2.3.2. Market
Estimation and Penetration, 2015 - 2021
9.2.3.3. Market
Forecast, 2022 - 2030
9.2.3.4. Compound
Annual Growth Rate (CAGR)
9.2.3.5. Regional
Bifurcation
9.2.3.5.1. North
America
9.2.3.5.1.1. Market
Estimation, 2015 - 2021
9.2.3.5.1.2. Market
Forecast, 2022 - 2030
9.2.3.5.2. Europe
9.2.3.5.2.1. Market
Estimation, 2015 - 2021
9.2.3.5.2.2. Market
Forecast, 2022 - 2030
9.2.3.5.3. Asia
Pacific
9.2.3.5.3.1. Market
Estimation, 2015 - 2021
9.2.3.5.3.2. Market
Forecast, 2022 - 2030
9.2.3.5.4. Middle
East and Africa
9.2.3.5.4.1. Market
Estimation, 2015 - 2021
9.2.3.5.4.2. Market
Forecast, 2022 - 2030
9.2.3.5.5. Latin
America
9.2.3.5.5.1. Market
Estimation, 2015 - 2021
9.2.3.5.5.2. Market
Forecast, 2022 - 2030
9.2.4. Specimen
management and storage
9.2.4.1. Definition
9.2.4.2. Market
Estimation and Penetration, 2015 - 2021
9.2.4.3. Market
Forecast, 2022 - 2030
9.2.4.4. Compound
Annual Growth Rate (CAGR)
9.2.4.5. Regional
Bifurcation
9.2.4.5.1. North
America
9.2.4.5.1.1. Market
Estimation, 2015 - 2021
9.2.4.5.1.2. Market
Forecast, 2022 - 2030
9.2.4.5.2. Europe
9.2.4.5.2.1. Market
Estimation, 2015 - 2021
9.2.4.5.2.2. Market
Forecast, 2022 - 2030
9.2.4.5.3. Asia
Pacific
9.2.4.5.3.1. Market
Estimation, 2015 - 2021
9.2.4.5.3.2. Market
Forecast, 2022 - 2030
9.2.4.5.4. Middle
East and Africa
9.2.4.5.4.1. Market
Estimation, 2015 - 2021
9.2.4.5.4.2. Market
Forecast, 2022 - 2030
9.2.4.5.5. Latin
America
9.2.4.5.5.1. Market
Estimation, 2015 - 2021
9.2.4.5.5.2. Market
Forecast, 2022 - 2030
9.2.5. Third-party
lab management
9.2.5.1. Definition
9.2.5.2. Market
Estimation and Penetration, 2015 - 2021
9.2.5.3. Market
Forecast, 2022 - 2030
9.2.5.4. Compound
Annual Growth Rate (CAGR)
9.2.5.5. Regional
Bifurcation
9.2.5.5.1. North
America
9.2.5.5.1.1. Market
Estimation, 2015 - 2021
9.2.5.5.1.2. Market
Forecast, 2022 - 2030
9.2.5.5.2. Europe
9.2.5.5.2.1. Market
Estimation, 2015 - 2021
9.2.5.5.2.2. Market
Forecast, 2022 - 2030
9.2.5.5.3. Asia
Pacific
9.2.5.5.3.1. Market
Estimation, 2015 - 2021
9.2.5.5.3.2. Market
Forecast, 2022 - 2030
9.2.5.5.4. Middle
East and Africa
9.2.5.5.4.1. Market
Estimation, 2015 - 2021
9.2.5.5.4.2. Market
Forecast, 2022 - 2030
9.2.5.5.5. Latin
America
9.2.5.5.5.1. Market
Estimation, 2015 - 2021
9.2.5.5.5.2. Market
Forecast, 2022 - 2030
9.2.6. Flow
Cytometry, Immunoassays and Biomarker Analysis
9.2.6.1. Definition
9.2.6.2. Market
Estimation and Penetration, 2015 - 2021
9.2.6.3. Market
Forecast, 2022 - 2030
9.2.6.4. Compound
Annual Growth Rate (CAGR)
9.2.6.5. Regional
Bifurcation
9.2.6.5.1. North
America
9.2.6.5.1.1. Market
Estimation, 2015 - 2021
9.2.6.5.1.2. Market
Forecast, 2022 - 2030
9.2.6.5.2. Europe
9.2.6.5.2.1. Market
Estimation, 2015 - 2021
9.2.6.5.2.2. Market
Forecast, 2022 - 2030
9.2.6.5.3. Asia
Pacific
9.2.6.5.3.1. Market
Estimation, 2015 - 2021
9.2.6.5.3.2. Market
Forecast, 2022 - 2030
9.2.6.5.4. Middle
East and Africa
9.2.6.5.4.1. Market
Estimation, 2015 - 2021
9.2.6.5.4.2. Market
Forecast, 2022 - 2030
9.2.6.5.5. Latin
America
9.2.6.5.5.1. Market
Estimation, 2015 - 2021
9.2.6.5.5.2. Market
Forecast, 2022 - 2030
9.2.7. Clinical
trial kit production
9.2.7.1. Definition
9.2.7.2. Market
Estimation and Penetration, 2015 - 2021
9.2.7.3. Market
Forecast, 2022 - 2030
9.2.7.4. Compound
Annual Growth Rate (CAGR)
9.2.7.5. Regional
Bifurcation
9.2.7.5.1. North
America
9.2.7.5.1.1. Market
Estimation, 2015 - 2021
9.2.7.5.1.2. Market
Forecast, 2022 - 2030
9.2.7.5.2. Europe
9.2.7.5.2.1. Market
Estimation, 2015 - 2021
9.2.7.5.2.2. Market
Forecast, 2022 - 2030
9.2.7.5.3. Asia
Pacific
9.2.7.5.3.1. Market
Estimation, 2015 - 2021
9.2.7.5.3.2. Market
Forecast, 2022 - 2030
9.2.7.5.4. Middle
East and Africa
9.2.7.5.4.1. Market
Estimation, 2015 - 2021
9.2.7.5.4.2. Market
Forecast, 2022 - 2030
9.2.7.5.5. Latin
America
9.2.7.5.5.1. Market
Estimation, 2015 - 2021
9.2.7.5.5.2. Market
Forecast, 2022 - 2030
9.2.8. Global
digital pathology
9.2.8.1. Definition
9.2.8.2. Market
Estimation and Penetration, 2015 - 2021
9.2.8.3. Market
Forecast, 2022 - 2030
9.2.8.4. Compound
Annual Growth Rate (CAGR)
9.2.8.5. Regional
Bifurcation
9.2.8.5.1. North
America
9.2.8.5.1.1. Market
Estimation, 2015 - 2021
9.2.8.5.1.2. Market
Forecast, 2022 - 2030
9.2.8.5.2. Europe
9.2.8.5.2.1. Market
Estimation, 2015 - 2021
9.2.8.5.2.2. Market
Forecast, 2022 - 2030
9.2.8.5.3. Asia
Pacific
9.2.8.5.3.1. Market
Estimation, 2015 - 2021
9.2.8.5.3.2. Market
Forecast, 2022 - 2030
9.2.8.5.4. Middle
East and Africa
9.2.8.5.4.1. Market
Estimation, 2015 - 2021
9.2.8.5.4.2. Market
Forecast, 2022 - 2030
9.2.8.5.5. Latin
America
9.2.8.5.5.1. Market
Estimation, 2015 - 2021
9.2.8.5.5.2. Market
Forecast, 2022 - 2030
9.2.9. Others
9.2.9.1. Definition
9.2.9.2. Market
Estimation and Penetration, 2015 - 2021
9.2.9.3. Market
Forecast, 2022 - 2030
9.2.9.4. Compound
Annual Growth Rate (CAGR)
9.2.9.5. Regional
Bifurcation
9.2.9.5.1. North
America
9.2.9.5.1.1. Market
Estimation, 2015 - 2021
9.2.9.5.1.2. Market
Forecast, 2022 - 2030
9.2.9.5.2. Europe
9.2.9.5.2.1. Market
Estimation, 2015 - 2021
9.2.9.5.2.2. Market
Forecast, 2022 - 2030
9.2.9.5.3. Asia
Pacific
9.2.9.5.3.1. Market
Estimation, 2015 - 2021
9.2.9.5.3.2. Market
Forecast, 2022 - 2030
9.2.9.5.4. Middle
East and Africa
9.2.9.5.4.1. Market
Estimation, 2015 - 2021
9.2.9.5.4.2. Market
Forecast, 2022 - 2030
9.2.9.5.5. Latin
America
9.2.9.5.5.1. Market
Estimation, 2015 - 2021
9.2.9.5.5.2. Market
Forecast, 2022 - 2030
9.3. Key
Segment for Channeling Investments
9.3.1. By
Offering
10. Global
Central Lab Market Analysis and Forecasts, 2022 – 2030
10.1. Overview
10.2. Global
Central Lab Market Revenue (US$ Mn) and Forecasts, By End User
10.2.1. Biotech
Companies
10.2.1.1. Definition
10.2.1.2. Market
Estimation and Penetration, 2015 - 2021
10.2.1.3. Market
Forecast, 2022 - 2030
10.2.1.4. Compound
Annual Growth Rate (CAGR)
10.2.1.5. Regional
Bifurcation
10.2.1.5.1. North
America
10.2.1.5.1.1. Market
Estimation, 2015 - 2021
10.2.1.5.1.2. Market
Forecast, 2022 - 2030
10.2.1.5.2. Europe
10.2.1.5.2.1. Market
Estimation, 2015 - 2021
10.2.1.5.2.2. Market
Forecast, 2022 - 2030
10.2.1.5.3. Asia
Pacific
10.2.1.5.3.1. Market
Estimation, 2015 - 2021
10.2.1.5.3.2. Market
Forecast, 2022 - 2030
10.2.1.5.4. Middle
East and Africa
10.2.1.5.4.1. Market
Estimation, 2015 - 2021
10.2.1.5.4.2. Market
Forecast, 2022 - 2030
10.2.1.5.5. Latin
America
10.2.1.5.5.1. Market
Estimation, 2015 - 2021
10.2.1.5.5.2. Market
Forecast, 2022 - 2030
10.2.2. Pharmaceutical
Companies
10.2.2.1. Definition
10.2.2.2. Market
Estimation and Penetration, 2015 - 2021
10.2.2.3. Market
Forecast, 2022 - 2030
10.2.2.4. Compound
Annual Growth Rate (CAGR)
10.2.2.5. Regional
Bifurcation
10.2.2.5.1. North
America
10.2.2.5.1.1. Market
Estimation, 2015 - 2021
10.2.2.5.1.2. Market
Forecast, 2022 - 2030
10.2.2.5.2. Europe
10.2.2.5.2.1. Market
Estimation, 2015 - 2021
10.2.2.5.2.2. Market
Forecast, 2022 - 2030
10.2.2.5.3. Asia
Pacific
10.2.2.5.3.1. Market
Estimation, 2015 - 2021
10.2.2.5.3.2. Market
Forecast, 2022 - 2030
10.2.2.5.4. Middle
East and Africa
10.2.2.5.4.1. Market
Estimation, 2015 - 2021
10.2.2.5.4.2. Market
Forecast, 2022 - 2030
10.2.2.5.5. Latin
America
10.2.2.5.5.1. Market
Estimation, 2015 - 2021
10.2.2.5.5.2. Market
Forecast, 2022 - 2030
10.2.3. CROs
10.2.3.1. Definition
10.2.3.2. Market
Estimation and Penetration, 2015 - 2021
10.2.3.3. Market
Forecast, 2022 - 2030
10.2.3.4. Compound
Annual Growth Rate (CAGR)
10.2.3.5. Regional
Bifurcation
10.2.3.5.1. North
America
10.2.3.5.1.1. Market
Estimation, 2015 - 2021
10.2.3.5.1.2. Market
Forecast, 2022 - 2030
10.2.3.5.2. Europe
10.2.3.5.2.1. Market
Estimation, 2015 - 2021
10.2.3.5.2.2. Market
Forecast, 2022 - 2030
10.2.3.5.3. Asia
Pacific
10.2.3.5.3.1. Market
Estimation, 2015 - 2021
10.2.3.5.3.2. Market
Forecast, 2022 - 2030
10.2.3.5.4. Middle
East and Africa
10.2.3.5.4.1. Market
Estimation, 2015 - 2021
10.2.3.5.4.2. Market
Forecast, 2022 - 2030
10.2.3.5.5. Latin
America
10.2.3.5.5.1. Market
Estimation, 2015 - 2021
10.2.3.5.5.2. Market
Forecast, 2022 - 2030
10.2.4. Others
10.2.4.1. Definition
10.2.4.2. Market
Estimation and Penetration, 2015 - 2021
10.2.4.3. Market
Forecast, 2022 - 2030
10.2.4.4. Compound
Annual Growth Rate (CAGR)
10.2.4.5. Regional
Bifurcation
10.2.4.5.1. North
America
10.2.4.5.1.1. Market
Estimation, 2015 - 2021
10.2.4.5.1.2. Market
Forecast, 2022 - 2030
10.2.4.5.2. Europe
10.2.4.5.2.1. Market
Estimation, 2015 - 2021
10.2.4.5.2.2. Market
Forecast, 2022 - 2030
10.2.4.5.3. Asia
Pacific
10.2.4.5.3.1. Market
Estimation, 2015 - 2021
10.2.4.5.3.2. Market
Forecast, 2022 - 2030
10.2.4.5.4. Middle
East and Africa
10.2.4.5.4.1. Market
Estimation, 2015 - 2021
10.2.4.5.4.2. Market
Forecast, 2022 - 2030
10.2.4.5.5. Latin
America
10.2.4.5.5.1. Market
Estimation, 2015 - 2021
10.2.4.5.5.2. Market
Forecast, 2022 - 2030
10.3. Key
Segment for Channeling Investments
10.3.1. By End
User
11. Global
Central Lab Market Analysis and Forecasts, 2022 – 2030
11.1. Overview
11.2. Global
Central Lab Market Revenue (US$ Mn) and Forecasts, By Areas
11.2.1. Oncology
11.2.1.1. Definition
11.2.1.2. Market
Estimation and Penetration, 2015 - 2021
11.2.1.3. Market
Forecast, 2022 - 2030
11.2.1.4. Compound
Annual Growth Rate (CAGR)
11.2.1.5. Regional
Bifurcation
11.2.1.5.1. North
America
11.2.1.5.1.1. Market
Estimation, 2015 - 2021
11.2.1.5.1.2. Market
Forecast, 2022 - 2030
11.2.1.5.2. Europe
11.2.1.5.2.1. Market
Estimation, 2015 - 2021
11.2.1.5.2.2. Market
Forecast, 2022 - 2030
11.2.1.5.3. Asia
Pacific
11.2.1.5.3.1. Market
Estimation, 2015 - 2021
11.2.1.5.3.2. Market
Forecast, 2022 - 2030
11.2.1.5.4. Middle
East and Africa
11.2.1.5.4.1. Market
Estimation, 2015 - 2021
11.2.1.5.4.2. Market
Forecast, 2022 - 2030
11.2.1.5.5. Latin
America
11.2.1.5.5.1. Market
Estimation, 2015 - 2021
11.2.1.5.5.2. Market
Forecast, 2022 - 2030
11.2.2. Infectious
diseases
11.2.2.1. Definition
11.2.2.2. Market
Estimation and Penetration, 2015 - 2021
11.2.2.3. Market
Forecast, 2022 - 2030
11.2.2.4. Compound
Annual Growth Rate (CAGR)
11.2.2.5. Regional
Bifurcation
11.2.2.5.1. North
America
11.2.2.5.1.1. Market
Estimation, 2015 - 2021
11.2.2.5.1.2. Market
Forecast, 2022 - 2030
11.2.2.5.2. Europe
11.2.2.5.2.1. Market
Estimation, 2015 - 2021
11.2.2.5.2.2. Market
Forecast, 2022 - 2030
11.2.2.5.3. Asia
Pacific
11.2.2.5.3.1. Market
Estimation, 2015 - 2021
11.2.2.5.3.2. Market
Forecast, 2022 - 2030
11.2.2.5.4. Middle
East and Africa
11.2.2.5.4.1. Market
Estimation, 2015 - 2021
11.2.2.5.4.2. Market
Forecast, 2022 - 2030
11.2.2.5.5. Latin
America
11.2.2.5.5.1. Market
Estimation, 2015 - 2021
11.2.2.5.5.2. Market
Forecast, 2022 - 2030
11.2.3. Auto-immune
disorders
11.2.3.1. Definition
11.2.3.2. Market
Estimation and Penetration, 2015 - 2021
11.2.3.3. Market
Forecast, 2022 - 2030
11.2.3.4. Compound
Annual Growth Rate (CAGR)
11.2.3.5. Regional
Bifurcation
11.2.3.5.1. North
America
11.2.3.5.1.1. Market
Estimation, 2015 - 2021
11.2.3.5.1.2. Market
Forecast, 2022 - 2030
11.2.3.5.2. Europe
11.2.3.5.2.1. Market
Estimation, 2015 - 2021
11.2.3.5.2.2. Market
Forecast, 2022 - 2030
11.2.3.5.3. Asia
Pacific
11.2.3.5.3.1. Market
Estimation, 2015 - 2021
11.2.3.5.3.2. Market
Forecast, 2022 - 2030
11.2.3.5.4. Middle
East and Africa
11.2.3.5.4.1. Market
Estimation, 2015 - 2021
11.2.3.5.4.2. Market
Forecast, 2022 - 2030
11.2.3.5.5. Latin
America
11.2.3.5.5.1. Market
Estimation, 2015 - 2021
11.2.3.5.5.2. Market
Forecast, 2022 - 2030
11.2.4. Immunology
11.2.4.1. Definition
11.2.4.2. Market
Estimation and Penetration, 2015 - 2021
11.2.4.3. Market
Forecast, 2022 - 2030
11.2.4.4. Compound
Annual Growth Rate (CAGR)
11.2.4.5. Regional
Bifurcation
11.2.4.5.1. North
America
11.2.4.5.1.1. Market
Estimation, 2015 - 2021
11.2.4.5.1.2. Market
Forecast, 2022 - 2030
11.2.4.5.2. Europe
11.2.4.5.2.1. Market
Estimation, 2015 - 2021
11.2.4.5.2.2. Market
Forecast, 2022 - 2030
11.2.4.5.3. Asia
Pacific
11.2.4.5.3.1. Market
Estimation, 2015 - 2021
11.2.4.5.3.2. Market
Forecast, 2022 - 2030
11.2.4.5.4. Middle
East and Africa
11.2.4.5.4.1. Market
Estimation, 2015 - 2021
11.2.4.5.4.2. Market
Forecast, 2022 - 2030
11.2.4.5.5. Latin
America
11.2.4.5.5.1. Market
Estimation, 2015 - 2021
11.2.4.5.5.2. Market
Forecast, 2022 - 2030
11.2.5. Gastroenterology
11.2.5.1. Definition
11.2.5.2. Market
Estimation and Penetration, 2015 - 2021
11.2.5.3. Market
Forecast, 2022 - 2030
11.2.5.4. Compound
Annual Growth Rate (CAGR)
11.2.5.5. Regional
Bifurcation
11.2.5.5.1. North
America
11.2.5.5.1.1. Market
Estimation, 2015 - 2021
11.2.5.5.1.2. Market
Forecast, 2022 - 2030
11.2.5.5.2. Europe
11.2.5.5.2.1. Market
Estimation, 2015 - 2021
11.2.5.5.2.2. Market
Forecast, 2022 - 2030
11.2.5.5.3. Asia
Pacific
11.2.5.5.3.1. Market
Estimation, 2015 - 2021
11.2.5.5.3.2. Market
Forecast, 2022 - 2030
11.2.5.5.4. Middle
East and Africa
11.2.5.5.4.1. Market
Estimation, 2015 - 2021
11.2.5.5.4.2. Market
Forecast, 2022 - 2030
11.2.5.5.5. Latin
America
11.2.5.5.5.1. Market
Estimation, 2015 - 2021
11.2.5.5.5.2. Market
Forecast, 2022 - 2030
11.2.6. Cardiology
11.2.6.1. Definition
11.2.6.2. Market
Estimation and Penetration, 2015 - 2021
11.2.6.3. Market
Forecast, 2022 - 2030
11.2.6.4. Compound
Annual Growth Rate (CAGR)
11.2.6.5. Regional
Bifurcation
11.2.6.5.1. North
America
11.2.6.5.1.1. Market
Estimation, 2015 - 2021
11.2.6.5.1.2. Market
Forecast, 2022 - 2030
11.2.6.5.2. Europe
11.2.6.5.2.1. Market
Estimation, 2015 - 2021
11.2.6.5.2.2. Market
Forecast, 2022 - 2030
11.2.6.5.3. Asia
Pacific
11.2.6.5.3.1. Market
Estimation, 2015 - 2021
11.2.6.5.3.2. Market
Forecast, 2022 - 2030
11.2.6.5.4. Middle
East and Africa
11.2.6.5.4.1. Market
Estimation, 2015 - 2021
11.2.6.5.4.2. Market
Forecast, 2022 - 2030
11.2.6.5.5. Latin
America
11.2.6.5.5.1. Market
Estimation, 2015 - 2021
11.2.6.5.5.2. Market
Forecast, 2022 - 2030
11.2.7. Endocrinology
11.2.7.1. Definition
11.2.7.2. Market
Estimation and Penetration, 2015 - 2021
11.2.7.3. Market
Forecast, 2022 - 2030
11.2.7.4. Compound
Annual Growth Rate (CAGR)
11.2.7.5. Regional
Bifurcation
11.2.7.5.1. North
America
11.2.7.5.1.1. Market
Estimation, 2015 - 2021
11.2.7.5.1.2. Market
Forecast, 2022 - 2030
11.2.7.5.2. Europe
11.2.7.5.2.1. Market
Estimation, 2015 - 2021
11.2.7.5.2.2. Market
Forecast, 2022 - 2030
11.2.7.5.3. Asia
Pacific
11.2.7.5.3.1. Market
Estimation, 2015 - 2021
11.2.7.5.3.2. Market
Forecast, 2022 - 2030
11.2.7.5.4. Middle
East and Africa
11.2.7.5.4.1. Market
Estimation, 2015 - 2021
11.2.7.5.4.2. Market
Forecast, 2022 - 2030
11.2.7.5.5. Latin
America
11.2.7.5.5.1. Market
Estimation, 2015 - 2021
11.2.7.5.5.2. Market
Forecast, 2022 - 2030
11.2.8. Respiratory
disorders
11.2.8.1. Definition
11.2.8.2. Market
Estimation and Penetration, 2015 - 2021
11.2.8.3. Market
Forecast, 2022 - 2030
11.2.8.4. Compound
Annual Growth Rate (CAGR)
11.2.8.5. Regional
Bifurcation
11.2.8.5.1. North
America
11.2.8.5.1.1. Market
Estimation, 2015 - 2021
11.2.8.5.1.2. Market
Forecast, 2022 - 2030
11.2.8.5.2. Europe
11.2.8.5.2.1. Market
Estimation, 2015 - 2021
11.2.8.5.2.2. Market
Forecast, 2022 - 2030
11.2.8.5.3. Asia
Pacific
11.2.8.5.3.1. Market
Estimation, 2015 - 2021
11.2.8.5.3.2. Market
Forecast, 2022 - 2030
11.2.8.5.4. Middle
East and Africa
11.2.8.5.4.1. Market
Estimation, 2015 - 2021
11.2.8.5.4.2. Market
Forecast, 2022 - 2030
11.2.8.5.5. Latin
America
11.2.8.5.5.1. Market
Estimation, 2015 - 2021
11.2.8.5.5.2. Market
Forecast, 2022 - 2030
11.2.9. Others
11.2.9.1. Definition
11.2.9.2. Market
Estimation and Penetration, 2015 - 2021
11.2.9.3. Market
Forecast, 2022 - 2030
11.2.9.4. Compound
Annual Growth Rate (CAGR)
11.2.9.5. Regional
Bifurcation
11.2.9.5.1. North
America
11.2.9.5.1.1. Market
Estimation, 2015 - 2021
11.2.9.5.1.2. Market
Forecast, 2022 - 2030
11.2.9.5.2. Europe
11.2.9.5.2.1. Market
Estimation, 2015 - 2021
11.2.9.5.2.2. Market
Forecast, 2022 - 2030
11.2.9.5.3. Asia
Pacific
11.2.9.5.3.1. Market
Estimation, 2015 - 2021
11.2.9.5.3.2. Market
Forecast, 2022 - 2030
11.2.9.5.4. Middle
East and Africa
11.2.9.5.4.1. Market
Estimation, 2015 - 2021
11.2.9.5.4.2. Market
Forecast, 2022 - 2030
11.2.9.5.5. Latin
America
11.2.9.5.5.1. Market
Estimation, 2015 - 2021
11.2.9.5.5.2. Market
Forecast, 2022 - 2030
11.3. Key
Segment for Channeling Investments
11.3.1. By
Areas
12. Global
Central Lab Market Analysis and Forecasts, 2022 – 2030
12.1. Overview
12.2. Global
Central Lab Market Revenue (US$ Mn) and Forecasts, By Application
12.2.1. Research
12.2.1.1. Definition
12.2.1.2. Market
Estimation and Penetration, 2015 - 2021
12.2.1.3. Market
Forecast, 2022 - 2030
12.2.1.4. Compound
Annual Growth Rate (CAGR)
12.2.1.5. Regional
Bifurcation
12.2.1.5.1. North
America
12.2.1.5.1.1. Market
Estimation, 2015 - 2021
12.2.1.5.1.2. Market
Forecast, 2022 - 2030
12.2.1.5.2. Europe
12.2.1.5.2.1. Market
Estimation, 2015 - 2021
12.2.1.5.2.2. Market
Forecast, 2022 - 2030
12.2.1.5.3. Asia
Pacific
12.2.1.5.3.1. Market
Estimation, 2015 - 2021
12.2.1.5.3.2. Market
Forecast, 2022 - 2030
12.2.1.5.4. Middle
East and Africa
12.2.1.5.4.1. Market
Estimation, 2015 - 2021
12.2.1.5.4.2. Market
Forecast, 2022 - 2030
12.2.1.5.5. Latin
America
12.2.1.5.5.1. Market
Estimation, 2015 - 2021
12.2.1.5.5.2. Market
Forecast, 2022 - 2030
12.2.2. Commercial
12.2.2.1. Definition
12.2.2.2. Market
Estimation and Penetration, 2015 - 2021
12.2.2.3. Market
Forecast, 2022 - 2030
12.2.2.4. Compound
Annual Growth Rate (CAGR)
12.2.2.5. Regional
Bifurcation
12.2.2.5.1. North
America
12.2.2.5.1.1. Market
Estimation, 2015 - 2021
12.2.2.5.1.2. Market
Forecast, 2022 - 2030
12.2.2.5.2. Europe
12.2.2.5.2.1. Market
Estimation, 2015 - 2021
12.2.2.5.2.2. Market
Forecast, 2022 - 2030
12.2.2.5.3. Asia
Pacific
12.2.2.5.3.1. Market
Estimation, 2015 - 2021
12.2.2.5.3.2. Market
Forecast, 2022 - 2030
12.2.2.5.4. Middle
East and Africa
12.2.2.5.4.1. Market
Estimation, 2015 - 2021
12.2.2.5.4.2. Market
Forecast, 2022 - 2030
12.2.2.5.5. Latin
America
12.2.2.5.5.1. Market
Estimation, 2015 - 2021
12.2.2.5.5.2. Market
Forecast, 2022 - 2030
12.3. Key
Segment for Channeling Investments
12.3.1. By
Application
13. North
America Central Lab Market Analysis and Forecasts, 2022 - 2030
13.1. Overview
13.1.1. North
America Central Lab Market Revenue (US$ Mn)
13.2. North
America Central Lab Market Revenue (US$ Mn) and Forecasts, By Type
13.2.1. Specialized
testing
13.2.2. High-volume
safety testing
13.2.3. Others
13.3. North
America Central Lab Market Revenue (US$ Mn) and Forecasts, By Offering
13.3.1. Project
management
13.3.2. Global
logistics and sample management
13.3.3. Data
management and analytics solutions
13.3.4. Specimen
management and storage
13.3.5. Third-party
lab management
13.3.6. Flow
Cytometry, Immunoassays and Biomarker Analysis
13.3.7. Clinical
trial kit production
13.3.8. Global
digital pathology
13.3.9. Others
13.4. North
America Central Lab Market Revenue (US$ Mn) and Forecasts, By End User
13.4.1. Biotech
Companies
13.4.2. Pharmaceutical
Companies
13.4.3. CROs
13.4.4. Others
13.5. North
America Central Lab Market Revenue (US$ Mn) and Forecasts, By Areas
13.5.1. Oncology
13.5.2. Infectious
diseases
13.5.3. Auto-immune
disorders
13.5.4. Immunology
13.5.5. Gastroenterology
13.5.6. Cardiology
13.5.7. Endocrinology
13.5.8. Respiratory
disorders
13.5.9. Others
13.6. North
America Central Lab Market Revenue (US$ Mn) and Forecasts, By Application
13.6.1. Research
13.6.2. Commercial
13.7. North
America Central Lab Market Revenue (US$ Mn) and Forecasts, By Country
13.7.1. U.S
13.7.1.1. U.S
Central Lab Market Revenue (US$ Mn) and Forecasts, By Type
13.7.1.1.1. Specialized
testing
13.7.1.1.2. High-volume
safety testing
13.7.1.1.3. Others
13.7.1.2. U.S
Central Lab Market Revenue (US$ Mn) and Forecasts, By Offering
13.7.1.2.1. Project
management
13.7.1.2.2. Global
logistics and sample management
13.7.1.2.3. Data
management and analytics solutions
13.7.1.2.4. Specimen
management and storage
13.7.1.2.5. Third-party
lab management
13.7.1.2.6. Flow
Cytometry, Immunoassays and Biomarker Analysis
13.7.1.2.7. Clinical
trial kit production
13.7.1.2.8. Global
digital pathology
13.7.1.2.9. Others
13.7.1.3. U.S
Central Lab Market Revenue (US$ Mn) and Forecasts, By End User
13.7.1.3.1. Biotech
Companies
13.7.1.3.2. Pharmaceutical
Companies
13.7.1.3.3. CROs
13.7.1.3.4. Others
13.7.1.4. U.S
Central Lab Market Revenue (US$ Mn) and Forecasts, By Areas
13.7.1.4.1. Oncology
13.7.1.4.2. Infectious
diseases
13.7.1.4.3. Auto-immune
disorders
13.7.1.4.4. Immunology
13.7.1.4.5. Gastroenterology
13.7.1.4.6. Cardiology
13.7.1.4.7. Endocrinology
13.7.1.4.8. Respiratory
disorders
13.7.1.4.9. Others
13.7.1.5. U.S
Central Lab Market Revenue (US$ Mn) and Forecasts, By Application
13.7.1.5.1. Research
13.7.1.5.2. Commercial
13.7.2. Canada
13.7.2.1. Canada
Central Lab Market Revenue (US$ Mn) and Forecasts, By Type
13.7.2.1.1. Specialized
testing
13.7.2.1.2. High-volume
safety testing
13.7.2.1.3. Others
13.7.2.2. Canada
Central Lab Market Revenue (US$ Mn) and Forecasts, By Offering
13.7.2.2.1. Project
management
13.7.2.2.2. Global
logistics and sample management
13.7.2.2.3. Data
management and analytics solutions
13.7.2.2.4. Specimen
management and storage
13.7.2.2.5. Third-party
lab management
13.7.2.2.6. Flow
Cytometry, Immunoassays and Biomarker Analysis
13.7.2.2.7. Clinical
trial kit production
13.7.2.2.8. Global
digital pathology
13.7.2.2.9. Others
13.7.2.3. Canada
Central Lab Market Revenue (US$ Mn) and Forecasts, By End User
13.7.2.3.1. Biotech
Companies
13.7.2.3.2. Pharmaceutical
Companies
13.7.2.3.3. CROs
13.7.2.3.4. Others
13.7.2.4. Canada
Central Lab Market Revenue (US$ Mn) and Forecasts, By Areas
13.7.2.4.1. Oncology
13.7.2.4.2. Infectious
diseases
13.7.2.4.3. Auto-immune
disorders
13.7.2.4.4. Immunology
13.7.2.4.5. Gastroenterology
13.7.2.4.6. Cardiology
13.7.2.4.7. Endocrinology
13.7.2.4.8. Respiratory
disorders
13.7.2.4.9. Others
13.7.2.5. Canada
Central Lab Market Revenue (US$ Mn) and Forecasts, By Application
13.7.2.5.1. Research
13.7.2.5.2. Commercial
13.7.3. Mexico
13.7.3.1. Mexico
Central Lab Market Revenue (US$ Mn) and Forecasts, By Type
13.7.3.1.1. Specialized
testing
13.7.3.1.2. High-volume
safety testing
13.7.3.1.3. Others
13.7.3.2. Mexico
Central Lab Market Revenue (US$ Mn) and Forecasts, By Offering
13.7.3.2.1. Project
management
13.7.3.2.2. Global
logistics and sample management
13.7.3.2.3. Data
management and analytics solutions
13.7.3.2.4. Specimen
management and storage
13.7.3.2.5. Third-party
lab management
13.7.3.2.6. Flow
Cytometry, Immunoassays and Biomarker Analysis
13.7.3.2.7. Clinical
trial kit production
13.7.3.2.8. Global
digital pathology
13.7.3.2.9. Others
13.7.3.3. Mexico
Central Lab Market Revenue (US$ Mn) and Forecasts, By End User
13.7.3.3.1. Biotech
Companies
13.7.3.3.2. Pharmaceutical
Companies
13.7.3.3.3. CROs
13.7.3.3.4. Others
13.7.3.4. Mexico
Central Lab Market Revenue (US$ Mn) and Forecasts, By Areas
13.7.3.4.1. Oncology
13.7.3.4.2. Infectious
diseases
13.7.3.4.3. Auto-immune
disorders
13.7.3.4.4. Immunology
13.7.3.4.5. Gastroenterology
13.7.3.4.6. Cardiology
13.7.3.4.7. Endocrinology
13.7.3.4.8. Respiratory
disorders
13.7.3.4.9. Others
13.7.3.5. Mexico
Central Lab Market Revenue (US$ Mn) and Forecasts, By Application
13.7.3.5.1. Research
13.7.3.5.2. Commercial
13.7.4. Rest of
North America
13.7.4.1. Rest
of North America Central Lab Market Revenue (US$ Mn) and Forecasts, By Type
13.7.4.1.1. Specialized
testing
13.7.4.1.2. High-volume
safety testing
13.7.4.1.3. Others
13.7.4.2. Rest
of North America Central Lab Market Revenue (US$ Mn) and Forecasts, By Offering
13.7.4.2.1. Project
management
13.7.4.2.2. Global
logistics and sample management
13.7.4.2.3. Data
management and analytics solutions
13.7.4.2.4. Specimen
management and storage
13.7.4.2.5. Third-party
lab management
13.7.4.2.6. Flow
Cytometry, Immunoassays and Biomarker Analysis
13.7.4.2.7. Clinical
trial kit production
13.7.4.2.8. Global
digital pathology
13.7.4.2.9. Others
13.7.4.3. Rest
of North America Central Lab Market Revenue (US$ Mn) and Forecasts, By End User
13.7.4.3.1. Biotech
Companies
13.7.4.3.2. Pharmaceutical
Companies
13.7.4.3.3. CROs
13.7.4.3.4. Others
13.7.4.4. Rest
of North America Central Lab Market Revenue (US$ Mn) and Forecasts, By Areas
13.7.4.4.1. Oncology
13.7.4.4.2. Infectious
diseases
13.7.4.4.3. Auto-immune
disorders
13.7.4.4.4. Immunology
13.7.4.4.5. Gastroenterology
13.7.4.4.6. Cardiology
13.7.4.4.7. Endocrinology
13.7.4.4.8. Respiratory
disorders
13.7.4.4.9. Others
13.7.4.5. Rest
of North America Central Lab Market Revenue (US$ Mn) and Forecasts, By
Application
13.7.4.5.1. Research
13.7.4.5.2. Commercial
13.8. Key
Segment for Channeling Investments
13.8.1. By
Country
13.8.2. By Type
13.8.3. By
Offering
13.8.4. By End
User
13.8.5. By
Areas
13.8.6. By
Application
14. Europe
Central Lab Market Analysis and Forecasts, 2022 - 2030
14.1. Overview
14.1.1. Europe
Central Lab Market Revenue (US$ Mn)
14.2. Europe
Central Lab Market Revenue (US$ Mn) and Forecasts, By Type
14.2.1. Specialized
testing
14.2.2. High-volume
safety testing
14.2.3. Others
14.3. Europe
Central Lab Market Revenue (US$ Mn) and Forecasts, By Offering
14.3.1. Project
management
14.3.2. Global
logistics and sample management
14.3.3. Data
management and analytics solutions
14.3.4. Specimen
management and storage
14.3.5. Third-party
lab management
14.3.6. Flow
Cytometry, Immunoassays and Biomarker Analysis
14.3.7. Clinical
trial kit production
14.3.8. Global
digital pathology
14.3.9. Others
14.4. Europe
Central Lab Market Revenue (US$ Mn) and Forecasts, By End User
14.4.1. Biotech
Companies
14.4.2. Pharmaceutical
Companies
14.4.3. CROs
14.4.4. Others
14.5. Europe
Central Lab Market Revenue (US$ Mn) and Forecasts, By Areas
14.5.1. Oncology
14.5.2. Infectious
diseases
14.5.3. Auto-immune
disorders
14.5.4. Immunology
14.5.5. Gastroenterology
14.5.6. Cardiology
14.5.7. Endocrinology
14.5.8. Respiratory
disorders
14.5.9. Others
14.6. Europe
Central Lab Market Revenue (US$ Mn) and Forecasts, By Application
14.6.1. Research
14.6.2. Commercial
14.7. Europe
Central Lab Market Revenue (US$ Mn) and Forecasts, By Country
14.7.1. France
14.7.1.1. France
Central Lab Market Revenue (US$ Mn) and Forecasts, By Type
14.7.1.1.1. Specialized
testing
14.7.1.1.2. High-volume
safety testing
14.7.1.1.3. Others
14.7.1.2. France
Central Lab Market Revenue (US$ Mn) and Forecasts, By Offering
14.7.1.2.1. Project
management
14.7.1.2.2. Global
logistics and sample management
14.7.1.2.3. Data
management and analytics solutions
14.7.1.2.4. Specimen
management and storage
14.7.1.2.5. Third-party
lab management
14.7.1.2.6. Flow
Cytometry, Immunoassays and Biomarker Analysis
14.7.1.2.7. Clinical
trial kit production
14.7.1.2.8. Global
digital pathology
14.7.1.2.9. Others
14.7.1.3. France
Central Lab Market Revenue (US$ Mn) and Forecasts, By End User
14.7.1.3.1. Biotech
Companies
14.7.1.3.2. Pharmaceutical
Companies
14.7.1.3.3. CROs
14.7.1.3.4. Others
14.7.1.4. France
Central Lab Market Revenue (US$ Mn) and Forecasts, By Areas
14.7.1.4.1. Oncology
14.7.1.4.2. Infectious
diseases
14.7.1.4.3. Auto-immune
disorders
14.7.1.4.4. Immunology
14.7.1.4.5. Gastroenterology
14.7.1.4.6. Cardiology
14.7.1.4.7. Endocrinology
14.7.1.4.8. Respiratory
disorders
14.7.1.4.9. Others
14.7.1.5. France
Central Lab Market Revenue (US$ Mn) and Forecasts, By Application
14.7.1.5.1. Research
14.7.1.5.2. Commercial
14.7.2. The UK
14.7.2.1. The
UK Central Lab Market Revenue (US$ Mn) and Forecasts, By Type
14.7.2.1.1. Specialized
testing
14.7.2.1.2. High-volume
safety testing
14.7.2.1.3. Others
14.7.2.2. The
UK Central Lab Market Revenue (US$ Mn) and Forecasts, By Offering
14.7.2.2.1. Project
management
14.7.2.2.2. Global
logistics and sample management
14.7.2.2.3. Data
management and analytics solutions
14.7.2.2.4. Specimen
management and storage
14.7.2.2.5. Third-party
lab management
14.7.2.2.6. Flow
Cytometry, Immunoassays and Biomarker Analysis
14.7.2.2.7. Clinical
trial kit production
14.7.2.2.8. Global
digital pathology
14.7.2.2.9. Others
14.7.2.3. The
UK Central Lab Market Revenue (US$ Mn) and Forecasts, By End User
14.7.2.3.1. Biotech
Companies
14.7.2.3.2. Pharmaceutical
Companies
14.7.2.3.3. CROs
14.7.2.3.4. Others
14.7.2.4. The
UK Central Lab Market Revenue (US$ Mn) and Forecasts, By Areas
14.7.2.4.1. Oncology
14.7.2.4.2. Infectious
diseases
14.7.2.4.3. Auto-immune
disorders
14.7.2.4.4. Immunology
14.7.2.4.5. Gastroenterology
14.7.2.4.6. Cardiology
14.7.2.4.7. Endocrinology
14.7.2.4.8. Respiratory
disorders
14.7.2.4.9. Others
14.7.2.5. The
UK Central Lab Market Revenue (US$ Mn) and Forecasts, By Application
14.7.2.5.1. Research
14.7.2.5.2. Commercial
14.7.3. Spain
14.7.3.1. Spain
Central Lab Market Revenue (US$ Mn) and Forecasts, By Type
14.7.3.1.1. Specialized
testing
14.7.3.1.2. High-volume
safety testing
14.7.3.1.3. Others
14.7.3.2. Spain
Central Lab Market Revenue (US$ Mn) and Forecasts, By Offering
14.7.3.2.1. Project
management
14.7.3.2.2. Global
logistics and sample management
14.7.3.2.3. Data
management and analytics solutions
14.7.3.2.4. Specimen
management and storage
14.7.3.2.5. Third-party
lab management
14.7.3.2.6. Flow
Cytometry, Immunoassays and Biomarker Analysis
14.7.3.2.7. Clinical
trial kit production
14.7.3.2.8. Global
digital pathology
14.7.3.2.9. Others
14.7.3.3. Spain
Central Lab Market Revenue (US$ Mn) and Forecasts, By End User
14.7.3.3.1. Biotech
Companies
14.7.3.3.2. Pharmaceutical
Companies
14.7.3.3.3. CROs
14.7.3.3.4. Others
14.7.3.4. Spain
Central Lab Market Revenue (US$ Mn) and Forecasts, By Areas
14.7.3.4.1. Oncology
14.7.3.4.2. Infectious
diseases
14.7.3.4.3. Auto-immune
disorders
14.7.3.4.4. Immunology
14.7.3.4.5. Gastroenterology
14.7.3.4.6. Cardiology
14.7.3.4.7. Endocrinology
14.7.3.4.8. Respiratory
disorders
14.7.3.4.9. Others
14.7.3.5. Spain
Central Lab Market Revenue (US$ Mn) and Forecasts, By Application
14.7.3.5.1. Research
14.7.3.5.2. Commercial
14.7.4. Germany
14.7.4.1. Germany
Central Lab Market Revenue (US$ Mn) and Forecasts, By Type
14.7.4.1.1. Specialized
testing
14.7.4.1.2. High-volume
safety testing
14.7.4.1.3. Others
14.7.4.2. Germany
Central Lab Market Revenue (US$ Mn) and Forecasts, By Offering
14.7.4.2.1. Project
management
14.7.4.2.2. Global
logistics and sample management
14.7.4.2.3. Data
management and analytics solutions
14.7.4.2.4. Specimen
management and storage
14.7.4.2.5. Third-party
lab management
14.7.4.2.6. Flow
Cytometry, Immunoassays and Biomarker Analysis
14.7.4.2.7. Clinical
trial kit production
14.7.4.2.8. Global
digital pathology
14.7.4.2.9. Others
14.7.4.3. Germany
Central Lab Market Revenue (US$ Mn) and Forecasts, By End User
14.7.4.3.1. Biotech
Companies
14.7.4.3.2. Pharmaceutical
Companies
14.7.4.3.3. CROs
14.7.4.3.4. Others
14.7.4.4. Germany
Central Lab Market Revenue (US$ Mn) and Forecasts, By Areas
14.7.4.4.1. Oncology
14.7.4.4.2. Infectious
diseases
14.7.4.4.3. Auto-immune
disorders
14.7.4.4.4. Immunology
14.7.4.4.5. Gastroenterology
14.7.4.4.6. Cardiology
14.7.4.4.7. Endocrinology
14.7.4.4.8. Respiratory
disorders
14.7.4.4.9. Others
14.7.4.5. Germany
Central Lab Market Revenue (US$ Mn) and Forecasts, By Application
14.7.4.5.1. Research
14.7.4.5.2. Commercial
14.7.5. Italy
14.7.5.1. Italy
Central Lab Market Revenue (US$ Mn) and Forecasts, By Type
14.7.5.1.1. Specialized
testing
14.7.5.1.2. High-volume
safety testing
14.7.5.1.3. Others
14.7.5.2. Italy
Central Lab Market Revenue (US$ Mn) and Forecasts, By Offering
14.7.5.2.1. Project
management
14.7.5.2.2. Global
logistics and sample management
14.7.5.2.3. Data
management and analytics solutions
14.7.5.2.4. Specimen
management and storage
14.7.5.2.5. Third-party
lab management
14.7.5.2.6. Flow
Cytometry, Immunoassays and Biomarker Analysis
14.7.5.2.7. Clinical
trial kit production
14.7.5.2.8. Global
digital pathology
14.7.5.2.9. Others
14.7.5.3. Italy
Central Lab Market Revenue (US$ Mn) and Forecasts, By End User
14.7.5.3.1. Biotech
Companies
14.7.5.3.2. Pharmaceutical
Companies
14.7.5.3.3. CROs
14.7.5.3.4. Others
14.7.5.4. Italy
Central Lab Market Revenue (US$ Mn) and Forecasts, By Areas
14.7.5.4.1. Oncology
14.7.5.4.2. Infectious
diseases
14.7.5.4.3. Auto-immune
disorders
14.7.5.4.4. Immunology
14.7.5.4.5. Gastroenterology
14.7.5.4.6. Cardiology
14.7.5.4.7. Endocrinology
14.7.5.4.8. Respiratory
disorders
14.7.5.4.9. Others
14.7.5.5. Italy
Central Lab Market Revenue (US$ Mn) and Forecasts, By Application
14.7.5.5.1. Research
14.7.5.5.2. Commercial
14.7.6. Nordic
Countries
14.7.6.1. Nordic
Countries Central Lab Market Revenue (US$ Mn) and Forecasts, By Type
14.7.6.1.1. Specialized
testing
14.7.6.1.2. High-volume
safety testing
14.7.6.1.3. Others
14.7.6.2. Nordic
Countries Central Lab Market Revenue (US$ Mn) and Forecasts, By Offering
14.7.6.2.1. Project
management
14.7.6.2.2. Global
logistics and sample management
14.7.6.2.3. Data
management and analytics solutions
14.7.6.2.4. Specimen
management and storage
14.7.6.2.5. Third-party
lab management
14.7.6.2.6. Flow
Cytometry, Immunoassays and Biomarker Analysis
14.7.6.2.7. Clinical
trial kit production
14.7.6.2.8. Global
digital pathology
14.7.6.2.9. Others
14.7.6.3. Nordic
Countries Central Lab Market Revenue (US$ Mn) and Forecasts, By End User
14.7.6.3.1. Biotech
Companies
14.7.6.3.2. Pharmaceutical
Companies
14.7.6.3.3. CROs
14.7.6.3.4. Others
14.7.6.4. Nordic
Countries Central Lab Market Revenue (US$ Mn) and Forecasts, By Areas
14.7.6.4.1. Oncology
14.7.6.4.2. Infectious
diseases
14.7.6.4.3. Auto-immune
disorders
14.7.6.4.4. Immunology
14.7.6.4.5. Gastroenterology
14.7.6.4.6. Cardiology
14.7.6.4.7. Endocrinology
14.7.6.4.8. Respiratory
disorders
14.7.6.4.9. Others
14.7.6.5. Nordic
Countries Central Lab Market Revenue (US$ Mn) and Forecasts, By Application
14.7.6.5.1. Research
14.7.6.5.2. Commercial
14.7.6.6. Nordic
Countries Central Lab Market Revenue (US$ Mn) and Forecasts, By Country
14.7.6.6.1. Denmark
14.7.6.6.2. Finland
14.7.6.6.3. Iceland
14.7.6.6.4. Sweden
14.7.6.6.5. Norway
14.7.7. Benelux
Union
14.7.7.1. Benelux
Union Central Lab Market Revenue (US$ Mn) and Forecasts, By Type
14.7.7.1.1. Specialized
testing
14.7.7.1.2. High-volume
safety testing
14.7.7.1.3. Others
14.7.7.2. Benelux
Union Central Lab Market Revenue (US$ Mn) and Forecasts, By Offering
14.7.7.2.1. Project
management
14.7.7.2.2. Global
logistics and sample management
14.7.7.2.3. Data
management and analytics solutions
14.7.7.2.4. Specimen
management and storage
14.7.7.2.5. Third-party
lab management
14.7.7.2.6. Flow
Cytometry, Immunoassays and Biomarker Analysis
14.7.7.2.7. Clinical
trial kit production
14.7.7.2.8. Global
digital pathology
14.7.7.2.9. Others
14.7.7.3. Benelux
Union Central Lab Market Revenue (US$ Mn) and Forecasts, By End User
14.7.7.3.1. Biotech
Companies
14.7.7.3.2. Pharmaceutical
Companies
14.7.7.3.3. CROs
14.7.7.3.4. Others
14.7.7.4. Benelux
Union Central Lab Market Revenue (US$ Mn) and Forecasts, By Areas
14.7.7.4.1. Oncology
14.7.7.4.2. Infectious
diseases
14.7.7.4.3. Auto-immune
disorders
14.7.7.4.4. Immunology
14.7.7.4.5. Gastroenterology
14.7.7.4.6. Cardiology
14.7.7.4.7. Endocrinology
14.7.7.4.8. Respiratory
disorders
14.7.7.4.9. Others
14.7.7.5. Benelux
Union Central Lab Market Revenue (US$ Mn) and Forecasts, By Application
14.7.7.5.1. Research
14.7.7.5.2. Commercial
14.7.7.6. Benelux
Union Central Lab Market Revenue (US$ Mn) and Forecasts, By Country
14.7.7.6.1. Belgium
14.7.7.6.2. The
Netherlands
14.7.7.6.3. Luxembourg
14.7.8. Rest of
Europe
14.7.8.1. Rest
of Europe Central Lab Market Revenue (US$ Mn) and Forecasts, By Type
14.7.8.1.1. Specialized
testing
14.7.8.1.2. High-volume
safety testing
14.7.8.1.3. Others
14.7.8.2. Rest
of Europe Central Lab Market Revenue (US$ Mn) and Forecasts, By Offering
14.7.8.2.1. Project
management
14.7.8.2.2. Global
logistics and sample management
14.7.8.2.3. Data
management and analytics solutions
14.7.8.2.4. Specimen
management and storage
14.7.8.2.5. Third-party
lab management
14.7.8.2.6. Flow
Cytometry, Immunoassays and Biomarker Analysis
14.7.8.2.7. Clinical
trial kit production
14.7.8.2.8. Global
digital pathology
14.7.8.2.9. Others
14.7.8.3. Rest
of Europe Central Lab Market Revenue (US$ Mn) and Forecasts, By End User
14.7.8.3.1. Biotech
Companies
14.7.8.3.2. Pharmaceutical
Companies
14.7.8.3.3. CROs
14.7.8.3.4. Others
14.7.8.4. Rest
of Europe Central Lab Market Revenue (US$ Mn) and Forecasts, By Areas
14.7.8.4.1. Oncology
14.7.8.4.2. Infectious
diseases
14.7.8.4.3. Auto-immune
disorders
14.7.8.4.4. Immunology
14.7.8.4.5. Gastroenterology
14.7.8.4.6. Cardiology
14.7.8.4.7. Endocrinology
14.7.8.4.8. Respiratory
disorders
14.7.8.4.9. Others
14.7.8.5. Rest
of Europe Central Lab Market Revenue (US$ Mn) and Forecasts, By Application
14.7.8.5.1. Research
14.7.8.5.2. Commercial
14.8. Key
Segment for Channeling Investments
14.8.1. By
Country
14.8.2. By Type
14.8.3. By
Offering
14.8.4. By End
User
14.8.5. By
Areas
14.8.6. By
Application
15. Asia
Pacific Central Lab Market Analysis and Forecasts, 2022 - 2030
15.1. Overview
15.1.1. Asia
Pacific Central Lab Market Revenue (US$ Mn)
15.2. Asia
Pacific Central Lab Market Revenue (US$ Mn) and Forecasts, By Type
15.2.1. Specialized
testing
15.2.2. High-volume
safety testing
15.2.3. Others
15.3. Asia
Pacific Central Lab Market Revenue (US$ Mn) and Forecasts, By Offering
15.3.1. Project
management
15.3.2. Global
logistics and sample management
15.3.3. Data
management and analytics solutions
15.3.4. Specimen
management and storage
15.3.5. Third-party
lab management
15.3.6. Flow
Cytometry, Immunoassays and Biomarker Analysis
15.3.7. Clinical
trial kit production
15.3.8. Global
digital pathology
15.3.9. Others
15.4. Asia
Pacific Central Lab Market Revenue (US$ Mn) and Forecasts, By End User
15.4.1. Biotech
Companies
15.4.2. Pharmaceutical
Companies
15.4.3. CROs
15.4.4. Others
15.5. Asia
Pacific Central Lab Market Revenue (US$ Mn) and Forecasts, By Areas
15.5.1. Oncology
15.5.2. Infectious
diseases
15.5.3. Auto-immune
disorders
15.5.4. Immunology
15.5.5. Gastroenterology
15.5.6. Cardiology
15.5.7. Endocrinology
15.5.8. Respiratory
disorders
15.5.9. Others
15.6. Asia
Pacific Central Lab Market Revenue (US$ Mn) and Forecasts, By Application
15.6.1. Research
15.6.2. Commercial
15.7. Asia
Pacific Central Lab Market Revenue (US$ Mn) and Forecasts, By Country
15.7.1. China
15.7.1.1. China
Central Lab Market Revenue (US$ Mn) and Forecasts, By Type
15.7.1.1.1. Specialized
testing
15.7.1.1.2. High-volume
safety testing
15.7.1.1.3. Others
15.7.1.2. China
Central Lab Market Revenue (US$ Mn) and Forecasts, By Offering
15.7.1.2.1. Project
management
15.7.1.2.2. Global
logistics and sample management
15.7.1.2.3. Data
management and analytics solutions
15.7.1.2.4. Specimen
management and storage
15.7.1.2.5. Third-party
lab management
15.7.1.2.6. Flow
Cytometry, Immunoassays and Biomarker Analysis
15.7.1.2.7. Clinical
trial kit production
15.7.1.2.8. Global
digital pathology
15.7.1.2.9. Others
15.7.1.3. China
Central Lab Market Revenue (US$ Mn) and Forecasts, By End User
15.7.1.3.1. Biotech
Companies
15.7.1.3.2. Pharmaceutical
Companies
15.7.1.3.3. CROs
15.7.1.3.4. Others
15.7.1.4. China
Central Lab Market Revenue (US$ Mn) and Forecasts, By Areas
15.7.1.4.1. Oncology
15.7.1.4.2. Infectious
diseases
15.7.1.4.3. Auto-immune
disorders
15.7.1.4.4. Immunology
15.7.1.4.5. Gastroenterology
15.7.1.4.6. Cardiology
15.7.1.4.7. Endocrinology
15.7.1.4.8. Respiratory
disorders
15.7.1.4.9. Others
15.7.1.5. China
Central Lab Market Revenue (US$ Mn) and Forecasts, By Application
15.7.1.5.1. Research
15.7.1.5.2. Commercial
15.7.2. Japan
15.7.2.1. Japan
Central Lab Market Revenue (US$ Mn) and Forecasts, By Type
15.7.2.1.1. Specialized
testing
15.7.2.1.2. High-volume
safety testing
15.7.2.1.3. Others
15.7.2.2. Japan
Central Lab Market Revenue (US$ Mn) and Forecasts, By Offering
15.7.2.2.1. Project
management
15.7.2.2.2. Global
logistics and sample management
15.7.2.2.3. Data
management and analytics solutions
15.7.2.2.4. Specimen
management and storage
15.7.2.2.5. Third-party
lab management
15.7.2.2.6. Flow
Cytometry, Immunoassays and Biomarker Analysis
15.7.2.2.7. Clinical
trial kit production
15.7.2.2.8. Global
digital pathology
15.7.2.2.9. Others
15.7.2.3. Japan
Central Lab Market Revenue (US$ Mn) and Forecasts, By End User
15.7.2.3.1. Biotech
Companies
15.7.2.3.2. Pharmaceutical
Companies
15.7.2.3.3. CROs
15.7.2.3.4. Others
15.7.2.4. Japan
Central Lab Market Revenue (US$ Mn) and Forecasts, By Areas
15.7.2.4.1. Oncology
15.7.2.4.2. Infectious
diseases
15.7.2.4.3. Auto-immune
disorders
15.7.2.4.4. Immunology
15.7.2.4.5. Gastroenterology
15.7.2.4.6. Cardiology
15.7.2.4.7. Endocrinology
15.7.2.4.8. Respiratory
disorders
15.7.2.4.9. Others
15.7.2.5. Japan
Central Lab Market Revenue (US$ Mn) and Forecasts, By Application
15.7.2.5.1. Research
15.7.2.5.2. Commercial
15.7.3. India
15.7.3.1. India
Central Lab Market Revenue (US$ Mn) and Forecasts, By Type
15.7.3.1.1. Specialized
testing
15.7.3.1.2. High-volume
safety testing
15.7.3.1.3. Others
15.7.3.2. India
Central Lab Market Revenue (US$ Mn) and Forecasts, By Offering
15.7.3.2.1. Project
management
15.7.3.2.2. Global
logistics and sample management
15.7.3.2.3. Data
management and analytics solutions
15.7.3.2.4. Specimen
management and storage
15.7.3.2.5. Third-party
lab management
15.7.3.2.6. Flow
Cytometry, Immunoassays and Biomarker Analysis
15.7.3.2.7. Clinical
trial kit production
15.7.3.2.8. Global
digital pathology
15.7.3.2.9. Others
15.7.3.3. India
Central Lab Market Revenue (US$ Mn) and Forecasts, By End User
15.7.3.3.1. Biotech
Companies
15.7.3.3.2. Pharmaceutical
Companies
15.7.3.3.3. CROs
15.7.3.3.4. Others
15.7.3.4. India
Central Lab Market Revenue (US$ Mn) and Forecasts, By Areas
15.7.3.4.1. Oncology
15.7.3.4.2. Infectious
diseases
15.7.3.4.3. Auto-immune
disorders
15.7.3.4.4. Immunology
15.7.3.4.5. Gastroenterology
15.7.3.4.6. Cardiology
15.7.3.4.7. Endocrinology
15.7.3.4.8. Respiratory
disorders
15.7.3.4.9. Others
15.7.3.5. India
Central Lab Market Revenue (US$ Mn) and Forecasts, By Application
15.7.3.5.1. Research
15.7.3.5.2. Commercial
15.7.4. New
Zealand
15.7.4.1. New
Zealand Central Lab Market Revenue (US$ Mn) and Forecasts, By Type
15.7.4.1.1. Specialized
testing
15.7.4.1.2. High-volume
safety testing
15.7.4.1.3. Others
15.7.4.2. New
Zealand Central Lab Market Revenue (US$ Mn) and Forecasts, By Offering
15.7.4.2.1. Project
management
15.7.4.2.2. Global
logistics and sample management
15.7.4.2.3. Data
management and analytics solutions
15.7.4.2.4. Specimen
management and storage
15.7.4.2.5. Third-party
lab management
15.7.4.2.6. Flow
Cytometry, Immunoassays and Biomarker Analysis
15.7.4.2.7. Clinical
trial kit production
15.7.4.2.8. Global
digital pathology
15.7.4.2.9. Others
15.7.4.3. New
Zealand Central Lab Market Revenue (US$ Mn) and Forecasts, By End User
15.7.4.3.1. Biotech
Companies
15.7.4.3.2. Pharmaceutical
Companies
15.7.4.3.3. CROs
15.7.4.3.4. Others
15.7.4.4. New
Zealand Central Lab Market Revenue (US$ Mn) and Forecasts, By Areas
15.7.4.4.1. Oncology
15.7.4.4.2. Infectious
diseases
15.7.4.4.3. Auto-immune
disorders
15.7.4.4.4. Immunology
15.7.4.4.5. Gastroenterology
15.7.4.4.6. Cardiology
15.7.4.4.7. Endocrinology
15.7.4.4.8. Respiratory
disorders
15.7.4.4.9. Others
15.7.4.5. New
Zealand Central Lab Market Revenue (US$ Mn) and Forecasts, By Application
15.7.4.5.1. Research
15.7.4.5.2. Commercial
15.7.5. Australia
15.7.5.1. Australia
Central Lab Market Revenue (US$ Mn) and Forecasts, By Type
15.7.5.1.1. Specialized
testing
15.7.5.1.2. High-volume
safety testing
15.7.5.1.3. Others
15.7.5.2. Australia
Central Lab Market Revenue (US$ Mn) and Forecasts, By Offering
15.7.5.2.1. Project
management
15.7.5.2.2. Global
logistics and sample management
15.7.5.2.3. Data
management and analytics solutions
15.7.5.2.4. Specimen
management and storage
15.7.5.2.5. Third-party
lab management
15.7.5.2.6. Flow
Cytometry, Immunoassays and Biomarker Analysis
15.7.5.2.7. Clinical
trial kit production
15.7.5.2.8. Global
digital pathology
15.7.5.2.9. Others
15.7.5.3. Australia
Central Lab Market Revenue (US$ Mn) and Forecasts, By End User
15.7.5.3.1. Biotech
Companies
15.7.5.3.2. Pharmaceutical
Companies
15.7.5.3.3. CROs
15.7.5.3.4. Others
15.7.5.4. Australia
Central Lab Market Revenue (US$ Mn) and Forecasts, By Areas
15.7.5.4.1. Oncology
15.7.5.4.2. Infectious
diseases
15.7.5.4.3. Auto-immune
disorders
15.7.5.4.4. Immunology
15.7.5.4.5. Gastroenterology
15.7.5.4.6. Cardiology
15.7.5.4.7. Endocrinology
15.7.5.4.8. Respiratory
disorders
15.7.5.4.9. Others
15.7.5.5. Australia
Central Lab Market Revenue (US$ Mn) and Forecasts, By Application
15.7.5.5.1. Research
15.7.5.5.2. Commercial
15.7.6. South
Korea
15.7.6.1. South
Korea Central Lab Market Revenue (US$ Mn) and Forecasts, By Type
15.7.6.1.1. Specialized
testing
15.7.6.1.2. High-volume
safety testing
15.7.6.1.3. Others
15.7.6.2. South
Korea Central Lab Market Revenue (US$ Mn) and Forecasts, By Offering
15.7.6.2.1. Project
management
15.7.6.2.2. Global
logistics and sample management
15.7.6.2.3. Data
management and analytics solutions
15.7.6.2.4. Specimen
management and storage
15.7.6.2.5. Third-party
lab management
15.7.6.2.6. Flow
Cytometry, Immunoassays and Biomarker Analysis
15.7.6.2.7. Clinical
trial kit production
15.7.6.2.8. Global
digital pathology
15.7.6.2.9. Others
15.7.6.3. South
Korea Central Lab Market Revenue (US$ Mn) and Forecasts, By End User
15.7.6.3.1. Biotech
Companies
15.7.6.3.2. Pharmaceutical
Companies
15.7.6.3.3. CROs
15.7.6.3.4. Others
15.7.6.4. South
Korea Central Lab Market Revenue (US$ Mn) and Forecasts, By Areas
15.7.6.4.1. Oncology
15.7.6.4.2. Infectious
diseases
15.7.6.4.3. Auto-immune
disorders
15.7.6.4.4. Immunology
15.7.6.4.5. Gastroenterology
15.7.6.4.6. Cardiology
15.7.6.4.7. Endocrinology
15.7.6.4.8. Respiratory
disorders
15.7.6.4.9. Others
15.7.6.5. South
Korea Central Lab Market Revenue (US$ Mn) and Forecasts, By Application
15.7.6.5.1. Research
15.7.6.5.2. Commercial
15.7.7. Southeast
Asia
15.7.7.1. Southeast
Asia Central Lab Market Revenue (US$ Mn) and Forecasts, By Type
15.7.7.1.1. Specialized
testing
15.7.7.1.2. High-volume
safety testing
15.7.7.1.3. Others
15.7.7.2. Southeast
Asia Central Lab Market Revenue (US$ Mn) and Forecasts, By Offering
15.7.7.2.1. Project
management
15.7.7.2.2. Global
logistics and sample management
15.7.7.2.3. Data
management and analytics solutions
15.7.7.2.4. Specimen
management and storage
15.7.7.2.5. Third-party
lab management
15.7.7.2.6. Flow
Cytometry, Immunoassays and Biomarker Analysis
15.7.7.2.7. Clinical
trial kit production
15.7.7.2.8. Global
digital pathology
15.7.7.2.9. Others
15.7.7.3. Southeast
Asia Central Lab Market Revenue (US$ Mn) and Forecasts, By End User
15.7.7.3.1. Biotech
Companies
15.7.7.3.2. Pharmaceutical
Companies
15.7.7.3.3. CROs
15.7.7.3.4. Others
15.7.7.4. Southeast
Asia Central Lab Market Revenue (US$ Mn) and Forecasts, By Areas
15.7.7.4.1. Oncology
15.7.7.4.2. Infectious
diseases
15.7.7.4.3. Auto-immune
disorders
15.7.7.4.4. Immunology
15.7.7.4.5. Gastroenterology
15.7.7.4.6. Cardiology
15.7.7.4.7. Endocrinology
15.7.7.4.8. Respiratory
disorders
15.7.7.4.9. Others
15.7.7.5. Southeast
Asia Central Lab Market Revenue (US$ Mn) and Forecasts, By Application
15.7.7.5.1. Research
15.7.7.5.2. Commercial
15.7.7.6. Southeast
Asia Central Lab Market Revenue (US$ Mn) and Forecasts, By Country
15.7.7.6.1. Indonesia
15.7.7.6.2. Thailand
15.7.7.6.3. Malaysia
15.7.7.6.4. Singapore
15.7.7.6.5. Rest
of Southeast Asia
15.7.8. Rest of
Asia Pacific
15.7.8.1. Rest
of Asia Pacific Central Lab Market Revenue (US$ Mn) and Forecasts, By Type
15.7.8.1.1. Specialized
testing
15.7.8.1.2. High-volume
safety testing
15.7.8.1.3. Others
15.7.8.2. Rest
of Asia Pacific Central Lab Market Revenue (US$ Mn) and Forecasts, By Offering
15.7.8.2.1. Project
management
15.7.8.2.2. Global
logistics and sample management
15.7.8.2.3. Data
management and analytics solutions
15.7.8.2.4. Specimen
management and storage
15.7.8.2.5. Third-party
lab management
15.7.8.2.6. Flow
Cytometry, Immunoassays and Biomarker Analysis
15.7.8.2.7. Clinical
trial kit production
15.7.8.2.8. Global
digital pathology
15.7.8.2.9. Others
15.7.8.3. Rest
of Asia Pacific Central Lab Market Revenue (US$ Mn) and Forecasts, By End User
15.7.8.3.1. Biotech
Companies
15.7.8.3.2. Pharmaceutical
Companies
15.7.8.3.3. CROs
15.7.8.3.4. Others
15.7.8.4. Rest
of Asia Pacific Central Lab Market Revenue (US$ Mn) and Forecasts, By Areas
15.7.8.4.1. Oncology
15.7.8.4.2. Infectious
diseases
15.7.8.4.3. Auto-immune
disorders
15.7.8.4.4. Immunology
15.7.8.4.5. Gastroenterology
15.7.8.4.6. Cardiology
15.7.8.4.7. Endocrinology
15.7.8.4.8. Respiratory
disorders
15.7.8.4.9. Others
15.7.8.5. Rest
of Asia Pacific Central Lab Market Revenue (US$ Mn) and Forecasts, By
Application
15.7.8.5.1. Research
15.7.8.5.2. Commercial
15.8. Key
Segment for Channeling Investments
15.8.1. By
Country
15.8.2. By Type
15.8.3. By Offering
15.8.4. By End
User
15.8.5. By
Areas
15.8.6. By
Application
16. Middle
East and Africa Central Lab Market Analysis and Forecasts, 2022 - 2030
16.1. Overview
16.1.1. Middle
East and Africa Central Lab Market Revenue (US$ Mn)
16.2. Middle
East and Africa Central Lab Market Revenue (US$ Mn) and Forecasts, By Type
16.2.1. Specialized
testing
16.2.2. High-volume
safety testing
16.2.3. Others
16.3. Middle
East and Africa Central Lab Market Revenue (US$ Mn) and Forecasts, By Offering
16.3.1. Project
management
16.3.2. Global
logistics and sample management
16.3.3. Data
management and analytics solutions
16.3.4. Specimen
management and storage
16.3.5. Third-party
lab management
16.3.6. Flow
Cytometry, Immunoassays and Biomarker Analysis
16.3.7. Clinical
trial kit production
16.3.8. Global
digital pathology
16.3.9. Others
16.4. Middle
East and Africa Central Lab Market Revenue (US$ Mn) and Forecasts, By End User
16.4.1. Biotech
Companies
16.4.2. Pharmaceutical
Companies
16.4.3. CROs
16.4.4. Others
16.5. Middle
East and Africa Central Lab Market Revenue (US$ Mn) and Forecasts, By Areas
16.5.1. Oncology
16.5.2. Infectious
diseases
16.5.3. Auto-immune
disorders
16.5.4. Immunology
16.5.5. Gastroenterology
16.5.6. Cardiology
16.5.7. Endocrinology
16.5.8. Respiratory
disorders
16.5.9. Others
16.6. Middle
East and Africa Central Lab Market Revenue (US$ Mn) and Forecasts, By
Application
16.6.1. Research
16.6.2. Commercial
16.7. Middle
East and Africa Central Lab Market Revenue (US$ Mn) and Forecasts, By Country
16.7.1. Saudi
Arabia
16.7.1.1. Saudi
Arabia Central Lab Market Revenue (US$ Mn) and Forecasts, By Type
16.7.1.1.1. Specialized
testing
16.7.1.1.2. High-volume
safety testing
16.7.1.1.3. Others
16.7.1.2. Saudi
Arabia Central Lab Market Revenue (US$ Mn) and Forecasts, By Offering
16.7.1.2.1. Project
management
16.7.1.2.2. Global
logistics and sample management
16.7.1.2.3. Data
management and analytics solutions
16.7.1.2.4. Specimen
management and storage
16.7.1.2.5. Third-party
lab management
16.7.1.2.6. Flow
Cytometry, Immunoassays and Biomarker Analysis
16.7.1.2.7. Clinical
trial kit production
16.7.1.2.8. Global
digital pathology
16.7.1.2.9. Others
16.7.1.3. Saudi
Arabia Central Lab Market Revenue (US$ Mn) and Forecasts, By End User
16.7.1.3.1. Biotech
Companies
16.7.1.3.2. Pharmaceutical
Companies
16.7.1.3.3. CROs
16.7.1.3.4. Others
16.7.1.4. Saudi
Arabia Central Lab Market Revenue (US$ Mn) and Forecasts, By Areas
16.7.1.4.1. Oncology
16.7.1.4.2. Infectious
diseases
16.7.1.4.3. Auto-immune
disorders
16.7.1.4.4. Immunology
16.7.1.4.5. Gastroenterology
16.7.1.4.6. Cardiology
16.7.1.4.7. Endocrinology
16.7.1.4.8. Respiratory
disorders
16.7.1.4.9. Others
16.7.1.5. Saudi
Arabia Central Lab Market Revenue (US$ Mn) and Forecasts, By Application
16.7.1.5.1. Research
16.7.1.5.2. Commercial
16.7.2. UAE
16.7.2.1. UAE
Central Lab Market Revenue (US$ Mn) and Forecasts, By Type
16.7.2.1.1. Specialized
testing
16.7.2.1.2. High-volume
safety testing
16.7.2.1.3. Others
16.7.2.2. UAE
Central Lab Market Revenue (US$ Mn) and Forecasts, By Offering
16.7.2.2.1. Project
management
16.7.2.2.2. Global
logistics and sample management
16.7.2.2.3. Data
management and analytics solutions
16.7.2.2.4. Specimen
management and storage
16.7.2.2.5. Third-party
lab management
16.7.2.2.6. Flow
Cytometry, Immunoassays and Biomarker Analysis
16.7.2.2.7. Clinical
trial kit production
16.7.2.2.8. Global
digital pathology
16.7.2.2.9. Others
16.7.2.3. UAE
Central Lab Market Revenue (US$ Mn) and Forecasts, By End User
16.7.2.3.1. Biotech
Companies
16.7.2.3.2. Pharmaceutical
Companies
16.7.2.3.3. CROs
16.7.2.3.4. Others
16.7.2.4. UAE
Central Lab Market Revenue (US$ Mn) and Forecasts, By Areas
16.7.2.4.1. Oncology
16.7.2.4.2. Infectious
diseases
16.7.2.4.3. Auto-immune
disorders
16.7.2.4.4. Immunology
16.7.2.4.5. Gastroenterology
16.7.2.4.6. Cardiology
16.7.2.4.7. Endocrinology
16.7.2.4.8. Respiratory
disorders
16.7.2.4.9. Others
16.7.2.5. UAE
Central Lab Market Revenue (US$ Mn) and Forecasts, By Application
16.7.2.5.1. Research
16.7.2.5.2. Commercial
16.7.3. Egypt
16.7.3.1. Egypt
Central Lab Market Revenue (US$ Mn) and Forecasts, By Type
16.7.3.1.1. Specialized
testing
16.7.3.1.2. High-volume
safety testing
16.7.3.1.3. Others
16.7.3.2. Egypt
Central Lab Market Revenue (US$ Mn) and Forecasts, By Offering
16.7.3.2.1. Project
management
16.7.3.2.2. Global
logistics and sample management
16.7.3.2.3. Data
management and analytics solutions
16.7.3.2.4. Specimen
management and storage
16.7.3.2.5. Third-party
lab management
16.7.3.2.6. Flow
Cytometry, Immunoassays and Biomarker Analysis
16.7.3.2.7. Clinical
trial kit production
16.7.3.2.8. Global
digital pathology
16.7.3.2.9. Others
16.7.3.3. Egypt
Central Lab Market Revenue (US$ Mn) and Forecasts, By End User
16.7.3.3.1. Biotech
Companies
16.7.3.3.2. Pharmaceutical
Companies
16.7.3.3.3. CROs
16.7.3.3.4. Others
16.7.3.4. Egypt
Central Lab Market Revenue (US$ Mn) and Forecasts, By Areas
16.7.3.4.1. Oncology
16.7.3.4.2. Infectious
diseases
16.7.3.4.3. Auto-immune
disorders
16.7.3.4.4. Immunology
16.7.3.4.5. Gastroenterology
16.7.3.4.6. Cardiology
16.7.3.4.7. Endocrinology
16.7.3.4.8. Respiratory
disorders
16.7.3.4.9. Others
16.7.3.5. Egypt
Central Lab Market Revenue (US$ Mn) and Forecasts, By Application
16.7.3.5.1. Research
16.7.3.5.2. Commercial
16.7.4. Kuwait
16.7.4.1. Kuwait
Central Lab Market Revenue (US$ Mn) and Forecasts, By Type
16.7.4.1.1. Specialized
testing
16.7.4.1.2. High-volume
safety testing
16.7.4.1.3. Others
16.7.4.2. Kuwait
Central Lab Market Revenue (US$ Mn) and Forecasts, By Offering
16.7.4.2.1. Project
management
16.7.4.2.2. Global
logistics and sample management
16.7.4.2.3. Data
management and analytics solutions
16.7.4.2.4. Specimen
management and storage
16.7.4.2.5. Third-party
lab management
16.7.4.2.6. Flow
Cytometry, Immunoassays and Biomarker Analysis
16.7.4.2.7. Clinical
trial kit production
16.7.4.2.8. Global
digital pathology
16.7.4.2.9. Others
16.7.4.3. Kuwait
Central Lab Market Revenue (US$ Mn) and Forecasts, By End User
16.7.4.3.1. Biotech
Companies
16.7.4.3.2. Pharmaceutical
Companies
16.7.4.3.3. CROs
16.7.4.3.4. Others
16.7.4.4. Kuwait
Central Lab Market Revenue (US$ Mn) and Forecasts, By Areas
16.7.4.4.1. Oncology
16.7.4.4.2. Infectious
diseases
16.7.4.4.3. Auto-immune
disorders
16.7.4.4.4. Immunology
16.7.4.4.5. Gastroenterology
16.7.4.4.6. Cardiology
16.7.4.4.7. Endocrinology
16.7.4.4.8. Respiratory
disorders
16.7.4.4.9. Others
16.7.4.5. Kuwait
Central Lab Market Revenue (US$ Mn) and Forecasts, By Application
16.7.4.5.1. Research
16.7.4.5.2. Commercial
16.7.5. South
Africa
16.7.5.1. South
Africa Central Lab Market Revenue (US$ Mn) and Forecasts, By Type
16.7.5.1.1. Specialized
testing
16.7.5.1.2. High-volume
safety testing
16.7.5.1.3. Others
16.7.5.2. South
Africa Central Lab Market Revenue (US$ Mn) and Forecasts, By Offering
16.7.5.2.1. Project
management
16.7.5.2.2. Global
logistics and sample management
16.7.5.2.3. Data
management and analytics solutions
16.7.5.2.4. Specimen
management and storage
16.7.5.2.5. Third-party
lab management
16.7.5.2.6. Flow
Cytometry, Immunoassays and Biomarker Analysis
16.7.5.2.7. Clinical
trial kit production
16.7.5.2.8. Global
digital pathology
16.7.5.2.9. Others
16.7.5.3. South
Africa Central Lab Market Revenue (US$ Mn) and Forecasts, By End User
16.7.5.3.1. Biotech
Companies
16.7.5.3.2. Pharmaceutical
Companies
16.7.5.3.3. CROs
16.7.5.3.4. Others
16.7.5.4. South
Africa Central Lab Market Revenue (US$ Mn) and Forecasts, By Areas
16.7.5.4.1. Oncology
16.7.5.4.2. Infectious
diseases
16.7.5.4.3. Auto-immune
disorders
16.7.5.4.4. Immunology
16.7.5.4.5. Gastroenterology
16.7.5.4.6. Cardiology
16.7.5.4.7. Endocrinology
16.7.5.4.8. Respiratory
disorders
16.7.5.4.9. Others
16.7.5.5. South
Africa Central Lab Market Revenue (US$ Mn) and Forecasts, By Application
16.7.5.5.1. Research
16.7.5.5.2. Commercial
16.7.6. Rest of
Middle East & Africa
16.7.6.1. Rest
of Middle East & Africa Central Lab Market Revenue (US$ Mn) and Forecasts,
By Type
16.7.6.1.1. Specialized
testing
16.7.6.1.2. High-volume
safety testing
16.7.6.1.3. Others
16.7.6.2. Rest
of Middle East & Africa Central Lab Market Revenue (US$ Mn) and Forecasts,
By Offering
16.7.6.2.1. Project
management
16.7.6.2.2. Global
logistics and sample management
16.7.6.2.3. Data
management and analytics solutions
16.7.6.2.4. Specimen
management and storage
16.7.6.2.5. Third-party
lab management
16.7.6.2.6. Flow
Cytometry, Immunoassays and Biomarker Analysis
16.7.6.2.7. Clinical
trial kit production
16.7.6.2.8. Global
digital pathology
16.7.6.2.9. Others
16.7.6.3. Rest
of Middle East & Africa Central Lab Market Revenue (US$ Mn) and Forecasts,
By End User
16.7.6.3.1. Biotech
Companies
16.7.6.3.2. Pharmaceutical
Companies
16.7.6.3.3. CROs
16.7.6.3.4. Others
16.7.6.4. Rest
of Middle East & Africa Central Lab Market Revenue (US$ Mn) and Forecasts,
By Areas
16.7.6.4.1. Oncology
16.7.6.4.2. Infectious
diseases
16.7.6.4.3. Auto-immune
disorders
16.7.6.4.4. Immunology
16.7.6.4.5. Gastroenterology
16.7.6.4.6. Cardiology
16.7.6.4.7. Endocrinology
16.7.6.4.8. Respiratory
disorders
16.7.6.4.9. Others
16.7.6.5. Rest
of Middle East & Africa Central Lab Market Revenue (US$ Mn) and Forecasts,
By Application
16.7.6.5.1. Research
16.7.6.5.2. Commercial
16.8. Key
Segment for Channeling Investments
16.8.1. By
Country
16.8.2. By Type
16.8.3. By
Offering
16.8.4. By End
User
16.8.5. By
Areas
16.8.6. By
Application
17. Latin
America Central Lab Market Analysis and Forecasts, 2022 - 2030
17.1. Overview
17.1.1. Latin
America Central Lab Market Revenue (US$ Mn)
17.2. Latin
America Central Lab Market Revenue (US$ Mn) and Forecasts, By Type
17.2.1. Specialized
testing
17.2.2. High-volume
safety testing
17.2.3. Others
17.3. Latin
America Central Lab Market Revenue (US$ Mn) and Forecasts, By Offering
17.3.1. Project
management
17.3.2. Global
logistics and sample management
17.3.3. Data
management and analytics solutions
17.3.4. Specimen
management and storage
17.3.5. Third-party
lab management
17.3.6. Flow
Cytometry, Immunoassays and Biomarker Analysis
17.3.7. Clinical
trial kit production
17.3.8. Global
digital pathology
17.3.9. Others
17.4. Latin
America Central Lab Market Revenue (US$ Mn) and Forecasts, By End User
17.4.1. Biotech
Companies
17.4.2. Pharmaceutical
Companies
17.4.3. CROs
17.4.4. Others
17.5. Latin
America Central Lab Market Revenue (US$ Mn) and Forecasts, By Areas
17.5.1. Oncology
17.5.2. Infectious
diseases
17.5.3. Auto-immune
disorders
17.5.4. Immunology
17.5.5. Gastroenterology
17.5.6. Cardiology
17.5.7. Endocrinology
17.5.8. Respiratory
disorders
17.5.9. Others
17.6. Latin
America Central Lab Market Revenue (US$ Mn) and Forecasts, By Application
17.6.1. Research
17.6.2. Commercial
17.7. Latin
America Central Lab Market Revenue (US$ Mn) and Forecasts, By Country
17.7.1. Brazil
17.7.1.1. Brazil
Central Lab Market Revenue (US$ Mn) and Forecasts, By Type
17.7.1.1.1. Specialized
testing
17.7.1.1.2. High-volume
safety testing
17.7.1.1.3. Others
17.7.1.2. Brazil
Central Lab Market Revenue (US$ Mn) and Forecasts, By Offering
17.7.1.2.1. Project
management
17.7.1.2.2. Global
logistics and sample management
17.7.1.2.3. Data
management and analytics solutions
17.7.1.2.4. Specimen
management and storage
17.7.1.2.5. Third-party
lab management
17.7.1.2.6. Flow
Cytometry, Immunoassays and Biomarker Analysis
17.7.1.2.7. Clinical
trial kit production
17.7.1.2.8. Global
digital pathology
17.7.1.2.9. Others
17.7.1.3. Brazil
Central Lab Market Revenue (US$ Mn) and Forecasts, By End User
17.7.1.3.1. Biotech
Companies
17.7.1.3.2. Pharmaceutical
Companies
17.7.1.3.3. CROs
17.7.1.3.4. Others
17.7.1.4. Brazil
Central Lab Market Revenue (US$ Mn) and Forecasts, By Areas
17.7.1.4.1. Oncology
17.7.1.4.2. Infectious
diseases
17.7.1.4.3. Auto-immune
disorders
17.7.1.4.4. Immunology
17.7.1.4.5. Gastroenterology
17.7.1.4.6. Cardiology
17.7.1.4.7. Endocrinology
17.7.1.4.8. Respiratory
disorders
17.7.1.4.9. Others
17.7.1.5. Brazil
Central Lab Market Revenue (US$ Mn) and Forecasts, By Application
17.7.1.5.1. Research
17.7.1.5.2. Commercial
17.7.2. Argentina
17.7.2.1. Argentina
Central Lab Market Revenue (US$ Mn) and Forecasts, By Type
17.7.2.1.1. Specialized
testing
17.7.2.1.2. High-volume
safety testing
17.7.2.1.3. Others
17.7.2.2. Argentina
Central Lab Market Revenue (US$ Mn) and Forecasts, By Offering
17.7.2.2.1. Project
management
17.7.2.2.2. Global
logistics and sample management
17.7.2.2.3. Data
management and analytics solutions
17.7.2.2.4. Specimen
management and storage
17.7.2.2.5. Third-party
lab management
17.7.2.2.6. Flow
Cytometry, Immunoassays and Biomarker Analysis
17.7.2.2.7. Clinical
trial kit production
17.7.2.2.8. Global
digital pathology
17.7.2.2.9. Others
17.7.2.3. Argentina
Central Lab Market Revenue (US$ Mn) and Forecasts, By End User
17.7.2.3.1. Biotech
Companies
17.7.2.3.2. Pharmaceutical
Companies
17.7.2.3.3. CROs
17.7.2.3.4. Others
17.7.2.4. Argentina
Central Lab Market Revenue (US$ Mn) and Forecasts, By Areas
17.7.2.4.1. Oncology
17.7.2.4.2. Infectious
diseases
17.7.2.4.3. Auto-immune
disorders
17.7.2.4.4. Immunology
17.7.2.4.5. Gastroenterology
17.7.2.4.6. Cardiology
17.7.2.4.7. Endocrinology
17.7.2.4.8. Respiratory
disorders
17.7.2.4.9. Others
17.7.2.5. Argentina
Central Lab Market Revenue (US$ Mn) and Forecasts, By Application
17.7.2.5.1. Research
17.7.2.5.2. Commercial
17.7.3. Rest of
Latin America
17.7.3.1. Rest
of Latin America Central Lab Market Revenue (US$ Mn) and Forecasts, By Type
17.7.3.1.1. Specialized
testing
17.7.3.1.2. High-volume
safety testing
17.7.3.1.3. Others
17.7.3.2. Rest
of Latin America Central Lab Market Revenue (US$ Mn) and Forecasts, By Offering
17.7.3.2.1. Project
management
17.7.3.2.2. Global
logistics and sample management
17.7.3.2.3. Data
management and analytics solutions
17.7.3.2.4. Specimen
management and storage
17.7.3.2.5. Third-party
lab management
17.7.3.2.6. Flow
Cytometry, Immunoassays and Biomarker Analysis
17.7.3.2.7. Clinical
trial kit production
17.7.3.2.8. Global
digital pathology
17.7.3.2.9. Others
17.7.3.3. Rest
of Latin America Central Lab Market Revenue (US$ Mn) and Forecasts, By End User
17.7.3.3.1. Biotech
Companies
17.7.3.3.2. Pharmaceutical
Companies
17.7.3.3.3. CROs
17.7.3.3.4. Others
17.7.3.4. Rest
of Latin America Central Lab Market Revenue (US$ Mn) and Forecasts, By Areas
17.7.3.4.1. Oncology
17.7.3.4.2. Infectious
diseases
17.7.3.4.3. Auto-immune
disorders
17.7.3.4.4. Immunology
17.7.3.4.5. Gastroenterology
17.7.3.4.6. Cardiology
17.7.3.4.7. Endocrinology
17.7.3.4.8. Respiratory
disorders
17.7.3.4.9. Others
17.7.3.5. Rest
of Latin America Central Lab Market Revenue (US$ Mn) and Forecasts, By
Application
17.7.3.5.1. Research
17.7.3.5.2. Commercial
17.8. Key
Segment for Channeling Investments
17.8.1. By
Country
17.8.2. By Type
17.8.3. By
Offering
17.8.4. By End
User
17.8.5. By
Areas
17.8.6. By
Application
18. Competitive
Benchmarking
18.1. Market
Share Analysis, 2021
18.2. Global
Presence and Growth Strategies
18.2.1. Mergers
and Acquisitions
18.2.2. Product
Launches
18.2.3. Investments
Trends
18.2.4. R&D
Initiatives
19. Player
Profiles
19.1. Labcorp
Drug Development
19.1.1. Company
Details
19.1.2. Company
Overview
19.1.3. Product
Offerings
19.1.4. Key
Developments
19.1.5. Financial
Analysis
19.1.6. SWOT
Analysis
19.1.7. Business
Strategies
19.2. Q2
Solutions
19.2.1. Company
Details
19.2.2. Company
Overview
19.2.3. Product
Offerings
19.2.4. Key
Developments
19.2.5. Financial
Analysis
19.2.6. SWOT
Analysis
19.2.7. Business
Strategies
19.3. Oncquest
19.3.1. Company
Details
19.3.2. Company
Overview
19.3.3. Product
Offerings
19.3.4. Key
Developments
19.3.5. Financial
Analysis
19.3.6. SWOT Analysis
19.3.7. Business
Strategies
19.4. ACM
Global Laboratories
19.4.1. Company
Details
19.4.2. Company
Overview
19.4.3. Product
Offerings
19.4.4. Key
Developments
19.4.5. Financial
Analysis
19.4.6. SWOT
Analysis
19.4.7. Business
Strategies
19.5. PPD Inc.
19.5.1. Company
Details
19.5.2. Company
Overview
19.5.3. Product
Offerings
19.5.4. Key
Developments
19.5.5. Financial
Analysis
19.5.6. SWOT
Analysis
19.5.7. Business
Strategies
19.6. ICON plc
19.6.1. Company
Details
19.6.2. Company
Overview
19.6.3. Product
Offerings
19.6.4. Key
Developments
19.6.5. Financial
Analysis
19.6.6. SWOT
Analysis
19.6.7. Business
Strategies
19.7. Eurofins
Central Laboratory
19.7.1. Company
Details
19.7.2. Company
Overview
19.7.3. Product
Offerings
19.7.4. Key
Developments
19.7.5. Financial
Analysis
19.7.6. SWOT
Analysis
19.7.7. Business
Strategies
19.8. Medpace
19.8.1. Company
Details
19.8.2. Company
Overview
19.8.3. Product
Offerings
19.8.4. Key
Developments
19.8.5. Financial
Analysis
19.8.6. SWOT
Analysis
19.8.7. Business
Strategies
19.9. LabConnect
19.9.1. Company
Details
19.9.2. Company
Overview
19.9.3. Product
Offerings
19.9.4. Key
Developments
19.9.5. Financial
Analysis
19.9.6. SWOT
Analysis
19.9.7. Business
Strategies
19.10. Other
Market Participants
20. Key
Findings
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
Reach to us
Call us on
+91-74002-42424
Drop us an email at
sales@absolutemarketsinsights.com
Why Absolute Markets Insights?
An effective strategy is the entity that influences a business to stand out of the crowd. An organization with a phenomenal strategy for success dependably has the edge over the rivals in the market. It offers the organizations a head start in planning their strategy. Absolute Market Insights is the new initiation in the industry that will furnish you with the lead your business needs. Absolute Market Insights is the best destination for your business intelligence and analytical solutions; essentially because our qualitative and quantitative sources of information are competent to give one-stop solutions. We inventively combine qualitative and quantitative research in accurate proportions to have the best report, which not only gives the most recent insights but also assists you to grow.